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Abstract 
A great variety of biochemical processes are either confined to or mediated by cellular 
membranes constructed around a framework provided by a compositionally heterogeneous 
and highly dynamic bilayer of phospholipid molecules. Accordingly, the physical 
properties and molecular organization of these mesoscopic supramolecular assemblies are 
regarded to represent pivotal determinants of the overall physiological state of cells.  
The present study aims to elucidate the modifications in the structure and functionality 
of the phospholipid matrix of biological membranes brought about by free radical-
mediated oxidative damage of its molecular constituents. To this end, monolayers of  two 
oxidatively modified phospholipids, viz. 1-palmitoyl-2-(9’-oxo-nonanoyl)-sn-glycero-3-
phosphocholine (PoxnoPC) and 1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine 
(PazePC) bearing an aldehyde or carboxyl function at the end of truncated sn-2 acyl chain, 
respectively, and their binary mixtures with 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
(DPPC) were studied using a Langmuir balance. The results obtained from measurements 
of force-area isotherms reveal both oxidized lipid species to have a significant impact on 
the structural dynamics of DPPC monolayers as illustrated by the appearance of a high-
pressure deflection, general expansion of the monolayer, and gradual disappearance of the 
liquid condensed-liquid expanded phase transition with increasing mole fraction of the 
oxidized lipid component. Moreover, surface potential measurements revealed 
considerable modifications in the electric properties of oxidized phospholipid containing 
monolayers during film compression, suggesting packing state-controlled reorientation of 
the intramolecular electric dipoles of the lipid headgroups and acyl chains. Based on the 
above findings, a model describing the conformational state of oxidized phospholipid 
molecules in biological membranes is proposed, involving the protrusion of the acyl 
chains bearing the polar functional groups out from the hydrocarbon phase to the 
surrounding aqueous medium. 
Oxidative modifications alter profoundly the physicochemical properties of 
unsaturated phospholipids and are therefore readily anticipated to have important 
implications for their interactions with membrane-associating molecules. Along these 
lines, PazePC was demonstrated to bind avidly the peripheral membrane protein 
cytochrome c using a fluorescence resonance energy transfer assay. The binding was 
reversed following increase in ionic strength or addition of polyanionic ATP, thus 
suggesting it to be driven by electrostatic interactions between cationic residues of the 
protein and the deprotonated carboxyl function of PazePC exposed to the aqueous phase. 
The presence of aldehyde function bearing PoxnoPC was observed to enhance the 
intercalation of four antimicrobial peptides into monomolecular films and liposomal 
bilayers of 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), as evidenced by 
changes in monolayer surface pressure and intrinsic tryptophan fluorescence of the 
peptides, respectively. Partitioning of the peptides to PoxnoPC containing monolayers was 
markedly attenuated by the aldehyde scavenger methoxyamine, revealing the PoxnoPC-
peptide interactions to be mediated by the carbonyl moiety possibly through efficient 
hydrogen bonding or, alternatively, formation of covalent adduct in form of a Schiff base 
between the lipid aldehydes and primary amine groups of the peptide molecules. Lastly, 
 
 
 
 
both  PazePC  and  PoxnoPC  were  observed  to  bind  with  high  affinity  three  small  
amphiphilic therapeutic agents, viz. chlorpromazine, haloperidol, and doxorubicin. 
Assessment  of  the  subsequent  dissociation  of  the  drugs  by  DNA,  NaCl  or  liposomes  
containing anionic phospholipids indicated the mechanism of binding to PoxnoPC to 
involve solely hydrophobic interactions, whereas significant contribution of electrostatics 
was evident in formation of PazePC-drug complexes. 
In conclusion, the results of biophysical studies conducted using Langmuir monolayers 
support the notion that oxidative damage of constituent molecules influences the 
molecular architecture as well as the bulk physicochemical properties of phospholipid 
membranes. Further, common polar functional groups carried by phospholipids subjected 
to oxidation were observed to act as molecular binding sites at the lipid-water interface. It 
is thus plausible that oxidized phospholipid species may elicit cellular level effects by 
modulating integration of various membrane-embedded and surface-associated proteins 
and peptides, whose conformational state, oligomerization, and functionality is known to 
be controlled by highly specific lipid-protein interactions and proper physical state of the 
membrane environment. 
 
 
 
 
 
 
 
 
 
Acknowledgements 
This study was carried out at the Department of Medical Biochemistry and Developmental 
Biology, Institute of Biomedicine, University of Helsinki. I thank professors Olli Jänne, 
Ismo Virtanen, and Esa Korpi for putting the facilities of the department at my disposal. 
The Mathematics and Science Fund of University of Helsinki and the Jenny and Antti 
Wihuri Foundation are acknowledged for their financial support. 
 
I owe thanks to my supervisor Professor Paavo Kinnunen for his guidance and mentoring. 
His profound scientific knowledge and enthusiasm towards new discoveries have been 
invaluable sources of inspiration. I also appreciate the independence and responsibility he 
trusted upon me during the course of this project.  
 
I wish to thank Professor Emeritus Ilmo Hassinen and Docent Vesa Olkkonen for their 
insightful and constructive criticism on the manuscript of this thesis, as well as Professor 
Hannu Sariola for agreeing to act as my custos at the public examination. 
 
I feel very fortunate to have met during my many years at HBBG numerous colleagues 
who I  now may call  friends.  My special  thanks  go  to  all  of  you  for  the  peer  support,  as  
well as for countless cheerful social events and get-togethers. The inspiring and laid-back 
atmosphere you guys helped to create in the lab has been essential for the completion of 
this thesis. 
 
The skillful and dedicated technical assistance of Kaija Niva and Kristiina Söderholm is 
highly appreciated. The expert secretarial support provided by Kaija Tiilikka, Johanna 
Nissinen, and Tiina Pasanen has alleviated various bureaucratic burdens along the way. 
 
I wish to thank my family and relatives for their support and encouragement during all 
these years. 
 
Lastly, I want to express my sincerest gratitude to my wife Karen for simply being there 
for me at all times. You bring love and happiness to my life every day. 
 
 
 
Helsinki, May 2009 
 
 
 
 
 
 
 
Contents 
Abstract 4 
Acknowledgements 6 
Contents 7 
List of original publications 10 
Abbreviations 11 
1 Introduction 14 
2 Review of the literature 16 
2.1 Overview of biological and model membranes 16 
2.1.1 Membranes are ubiquitous in living cells 17 
2.1.2 Model membranes 19 
2.1.3 Physical properties and phase behavior of phospholipid aggregates 21 
2.2 Phospholipid oxidation 24 
2.2.1 The sources of oxidized phospholipids 25 
2.2.2 Physiological impact of phospholipid oxidation products 27 
2.2.3 The role of phospholipid oxidation in human pathophysiology 29 
3 Outline of the present study 32 
4 Materials and methods 33 
4.1 Materials 33 
4.2 Preparation of unilamellar vesicles and lipid dispersions  34 
4.3 Surface tension and monolayer measurements  35 
4.3.1 Monolayer compression isotherms 35 
4.3.2 Monolayer fluorescence microscopy 36 
4.3.3 CMC determination 36 
4.3.4 Penetration of peptides into lipid monolayers 37 
 
 
 
 
4.4 Fluorescence spectroscopy  37 
4.4.1 Steady-state fluorescence measurements 37 
4.4.2 Determination of drug-membrane molar partition coefficients 39 
4.4.3 Quenching of tryptophan emission by acrylamide 39 
4.5 Dynamic light scattering  40 
5 Results 41 
5.1 Interfacial properties of two oxidized phospholipids 41 
5.1.1 Determination of critical micelle concentrations 41 
5.1.2 Force-area isotherms for mixed oxPL/DPPC monolayers 42 
5.1.3 Changes in the monolayer surface potential 43 
5.1.4 Fluorescence microscopy of the monolayers 45 
5.2 Interactions of cationic drugs and cyt c with oxPL aggregates 46 
5.2.1 Binding of drugs to oxPLs 46 
5.2.2 Molecular interactions between oxPLs and cyt c 49 
5.3 Impact of oxPLs on the association of antimicrobial peptides with model 
membranes 51 
5.3.1 Penetration of peptides into phospholipid monolayers 51 
5.3.2 Peptide Trp fluorescence 55 
6 Discussion 58 
6.1 The impact of oxidative modifications on the structural dynamics of  
phospholipid membranes 58 
6.1.1 Extended lipid conformation involving the oxidatively modified sn-2  
chains 58 
6.2 Molecular interactions of oxidized phospholipids with amphipathic drugs and 
peptides 62 
6.2.1 Oxidized phospholipids retain therapeutic agents through noncovalent 
interactions: possible pharmacological implications 63 
6.2.2 Membrane association of AMPs is promoted by PoxnoPC 67 
 
 
 
 
References 72 
Original publications
 
 
 
 
10 
List of original publications 
This  thesis  is  based  on  the  following  publications,  referred  to  in  the  text  by  their  roman 
numerals: 
 
I Karen Sabatini, Juha-Pekka Mattila, Francesco M. Megli, and Paavo K. 
J. Kinnunen. Characterization of the Surface Properties of two Oxidatively 
Modified Phospholipids in Mixed Monolayers with DPPC. (2006) Biophys. 
J. 90:4488-4499. 
  
II Juha-Pekka Mattila, Karen Sabatini, and Paavo K. J. Kinnunen. 
Oxidized Phospholipids as Potential Novel Drug Targets. (2007) Biophys. J. 
93:3105-3112.  
 
III Juha-Pekka Mattila*, Karen Sabatini*, and Paavo K. J. Kinnunen. 
Oxidized Phospholipids as Potential Molecular Targets for Antimicrobial 
Peptides. (2008) Biochim. Biophys. Acta 1778:2041-2050. 
 
IV Juha-Pekka Mattila, Karen Sabatini, and Paavo K. J. Kinnunen. 
Interaction of Cytochrome c with 1-palmitoyl-2-azelaoyl-sn-glycero-3-
phosphocholine: Evidence for Acyl Chain Reversal. (2008) Langmuir 
24:4157-4160. 
 
*Equal contribution 
 
Publication I has previously been used as a part of PhD Karen Sabatini’s dissertation 
“Lipoxidation: Effects on the Structure and Function of Biological Membranes”, 2006, 
University of Bari, Italy. 
 
The publications have been reproduced with permission of their copyright holders. 
 
 
 
 
11
Abbreviations 
A area per molecule 
AS apparent molecular cross sectional area 
a0 optimum headgroup area 
AA arachidonic acid 
AH free radical inhibitor 
AMP antimicrobial peptide 
?? amyloid ?-protein 
c concentration 
CS monolayer isothermal compressibility 
CMC critical micelle concentration 
CPZ chlorpromazine 
cyt c cytochrome c 
D diffusion coefficient 
DHA docosahexaenoic acid 
DLS dynamic light scattering 
DMPC 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
DMPG 1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] 
DMSO dimethyl sulfoxide 
DOX doxorubicin 
DPH diphenylhexatriene 
DPPC 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
eggPC egg yolk phosphatidylcholine 
EDTA ethylenediaminetetraacetic acid 
EPR electron paramagnetic resonance 
FTIR Fourier transform infrared 
F fluorescence intensity 
GUV giant unilamellar vesicle 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HNE 4-hydroxy-2-trans-nonenal 
HPD haloperidol 
IL-8 interleukin 8 
kB Boltzmann constant 
Kp molar partition coefficient 
KSV Stern-Volmer quenching constant 
Ksw apparent air-water partitioning coefficient 
lc critical chain length 
L? lamellar disordered fluid phase 
L? lamellar ordered gel phase 
L• lipid radical 
LA linoleic acid 
LC liquid condensed 
LDL low density lipoprotein 
 
 
 
 
12 
LE liquid expanded 
LOO• lipid peroxyl radical 
LOOH lipid hydroperoxide 
LUV large unilamellar vesicle 
lysoPC 1-palmitoyl-2-lyso-sn-glycero-3-phosphocholine 
MCP-1 monocyte chemoattractant protein 1 
MDA malondialdehyde 
MES 2-(N-morpholino)ethanesulfonic acid 
MLV multilamellar vesicle 
NA Avogadro’s number 
NBD-PC 1-palmitoyl-2-(N-4-nitrobenz-2-oxa-1,3-diazol)aminocaproyl-sn-glycero-3-
phosphocholine 
ONOO- peroxynitrite 
oxPL oxidized phospholipid 
p packing parameter 
PazePC 1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine 
PLPC 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphatidylcholine 
PoxnoPC 1-palmitoyl-2-(9’-oxo-nonanoyl)-sn-glycero-3-phosphocholine 
POPC 1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine 
POPS 1-palmitoyl-2-oleyl-sn-glycero-3-phospho-L-serine 
PPDPC 1-palmitoyl-2-[10-(pyren-1-yl)decanoyl]-sn-glycero-3-phosphocholine 
PRR pattern-recognition receptor 
PUFA polyunsaturated fatty acid 
r hydrodynamic radius 
R gas constant 
RFI relative fluorescence intensity 
RFQ reversal of fluorescence quenching 
RO• alkoxyl radical 
ROO• peroxyl radical 
ROOH organic hydroperoxide 
ROS reactive oxygen species 
SUV small unilamellar vesicle 
T temperature 
Tm main transition temperature 
v hydrocarbon volume  
XY mole fraction of compound Y 
? surface excess 
?? change of surface pressure 
?? monolayer surface potential 
? surface tension 
? viscosity 
? wavelength 
? chemical potential 
 
 
 
 
13
?? the component of the monolayer dipole moment vector perpendicular to the 
monolayer plane 
? surface pressure 
?0 initial surface pressure 
?c critical packing pressure 
?s critical pressure for dissolving of oxidized phospholipids 
 14 
 
 
 
1 Introduction 
Biological membranes are exceedingly complex supramolecular composites of lipids, 
proteins, and carbohydrates. Their universal structural basis is provided by a 30 Å thick 
continuous double layer of amphipathic phospholipid molecules generally idealized as a 
highly anisotropic two-dimensional liquid where nonrandom and nonuniform 
spatiotemporal organization prevails through a delicate balance of noncovalent 
interactions (Kinnunen, 1991; Jørgensen et al., 1993; Mouritsen and Kinnunen, 1996). In 
eukaryotic cells, the distinct arrays of phospholipid species constituting the plasma 
membrane and the membranes delimiting the discrete organelles are stringently 
maintained through active metabolism and selective transport so as to ensure that each 
cellular membrane is provided with a specific steady-state lipid composition reflecting the 
requirements set by its unique functional role (Colbeau et al., 1971; Wolf and Quinn, 
2004). Advances in multidisciplinary membrane research have provided fundamental 
insights into the intimate coupling between the chemical composition of lipid bilayers and 
their structural and biophysical properties. Accordingly, it has become apparent that the 
general physicochemical characteristics of a membrane, such as its phase behavior, 
thickness, curvature strain, elasticity, lateral pressure profile, and surface charge density 
are governed by the chemical nature of membrane lipids as well as their heterogeneous 
lateral and transversal organization into compositionally differentiated regions (Janmey 
and Kinnunen, 2006). Further, these properties of lipid bilayers are increasingly 
recognized to play salient roles in the attachment and functionality of membrane proteins 
and therefore have far-reaching physiological implications (Nyholm et al., 2007, Escribá 
et al., 2008). 
Due to abundance of molecular species bearing unsaturated acyl chains, the 
phospholipid matrix of eukaryotic membranes is highly prone to oxidative modification by 
reactive oxygen species (ROS), which comprise both organic and inorganic by-products of 
cellular metabolism. Although under normal conditions ROS are efficiently detoxified by 
cells via various antioxidant mechanisms, their mediated oxidative damage on biological 
macromolecules is known to accumulate in tissues upon aging as well as in various 
pathological states (Halliwell and Gutteridge, 1990). Once initiated, phospholipid 
oxidation proceeds as a chain reaction causing loss of double bonds of acyl chains together 
with their concomitant fragmentation and formation of polar hydroperoxy, aldehyde, and 
carboxyl groups to the hydrophobic membrane interior. These chemical events generate a 
myriad of molecules with profoundly different physicochemical properties from the parent 
phosholipids,  and  as  result,  local  alterations  in  the  structure  and  dynamics  of  the  bilayer  
are readily expected. Moreover, several distinct phospholipid oxidation products possess 
biological activity and are implicated in specific signaling pathways associated with 
events such as apoptosis and inflammation (Deigner and Hermetter, 2008). Finally, 
oxidatively modified phospholipids as well as their soluble fragments generated by 
oxidative damage have been demonstrated to induce misfolding of diverse polypeptide 
chains leading to their malfunction and aggregation (Bieschke et al., 2006; Murray et al., 
2007). 
INTRODUCTION 
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The present study was motivated by the current paucity in experimental data regarding 
the manifestations of phospholipid oxidation on the molecular level. Various biophysical 
techniques were utilized to assess the surface chemical properties of two synthetic 
oxidatively modified phospholipids together with their impact on the structural dynamics 
of model membrane systems. Further, the putative role of the functional groups borne by 
oxidized phospholipids as mediators of molecular interactions was investigated using 
membrane-associating peptides and amphiphilic oxidative stress-inducing drugs. The 
thesis will open with a literature review where the reader is introduced to the fundamental 
features of biomembranes as well as the chemical and biological aspects of phospholipid 
oxidation according to current knowledge. In the next section, the methodology used is 
outlined whereafter the results obtained from the experiments are presented. The thesis is 
closed by discussion of the results in the context of their apparent biological implications. 
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2 Review of the literature 
2.1 Overview of biological and model membranes 
Today, the study of structure and function of biomembranes represents a unique 
interdisciplinary challenge for scientists with seemingly unrelated backgrounds ranging 
from molecular biology to theoretical physics (Mouritsen, 2005). Yet for decades, the 
scientific interest in biological membranes was overshadowed by the commendable 
breakthroughs achieved in the fields of genomics and proteomics in unraveling how living 
systems function. In this context the core constituents of membranes, lipids, were viewed 
as abundant but obscure molecules carrying out a trivial structural task in cellular 
physiology. Nonetheless, novel conceptual frameworks formulated on the basis of certain 
key experimental findings helped to reverse this conviction and subsequently served as the 
main impetus leading to a more widespread recognition of the salient role of this 
previously overlooked class of biomolecules. Among them, the fluid-mosaic model of 
Singer and Nicolson (1972) deserves a particular mention since – although vague and 
obsolete in the light of present knowledge – it introduced the fundamental concept of 
fluidity to membrane science by portraying lipid membranes as pseudo two-dimensional 
asymmetrical liquids allowing for the lateral mobility of their individual molecular 
components. Thus the fluid-mosaic model represents the first step towards current 
paradigm of biological membranes as dynamic composites of lipids and proteins 
displaying physiologically relevant functional ordering on multiple time and length scales 
(Israelachvili, 1977; Sackmann, 1995). There is also accumulating evidence suggesting 
that numerous biochemical reactions and enzymatic processes take place on surfaces of 
cellular membranes and many of them are profoundly influenced following alterations in 
membrane physicochemical properties (Op den Kamp et al., 1975; Cantor, 1997a; Jensen 
and Mouritsen, 2004). Lastly, individual lipid molecules have also been found to possess 
important roles as second messengers triggering essential physiological processes 
including inflammation, proliferation, and apoptosis (Dennis et al., 1991; Spiegel et al., 
1996), hence implicating membrane structures as reservoirs of transducers involved in 
cellular signaling.  
From the point of view of materials science, biomembranes are so-called soft 
condensed matter with intriguing functional features (Mouritsen, 2005). Particularly the 
propensity to self-assemble in aqueous solutions into complex supramolecular structures 
displaying a rich variety of phases and connecting transitions arising from subtle balance 
of energy and entropy is a central characteristic of lipid membranes (Kinnunen and 
Laggner, 1991, Heimburg, 2000). In addition, these collective and cooperative molecular 
phenomena along with often non-ideal mixing of membrane constituents manifest as 
intricate structural functionality that is highly responsive to changes in the physical and 
chemical properties of the surrounding environment. The above translates in many 
respects into mechanically and functionally superior properties compared to man-made 
materials. Therefore it is not surprising that many biotechnological and -medical 
applications including drug and gene delivery formulations (Felgner et al., 1987; Allen, 
REVIEW OF THE LITERATURE 
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1998; Peñate-Medina et al., 2004) as well as biosensors (Tien et al., 1991; Nikolelis and 
Krull, 1993) make use of biomimetic membranes especially when nanoscopic 
organization, encapsulation, and controlled release are desired.    
2.1.1 Dynamic membranes are ubiquitous in living cells 
When a eukaryotic cell is observed under an electron microscope, bilayer structures 
including the plasma membrane as well as the membranes of subcellular organelles such 
as the nucleus, mitochondria, endoplasmic reticulum, and the Golgi apparatus are clearly 
discernible and appear to fill a large part of the intracellular volume (Fig. 2.1). Upon 
analysis of such stagnant images a role for lipid bilayers as insulators separating two 
aqueous volumes is readily deduced. Regrettably, this rather limited view on their 
functional significance is still emphasized in several major textbooks of cell biology and 
biochemistry (see e.g. Alberts et al., 2002; Nelson and Cox, 2005). Yet, as such, the task 
of the passive semipermeable barrier is by no means a redundant one, as it acts to define 
the boundaries of the cell and its organelles and concomitantly allows for the upkeep of 
the vital chemical gradients across them. Moreover, it lends itself as anisotropic molecular 
scaffolding for the anchoring of the other building blocks of biomembranes, namely 
proteins and carbohydrates conferring the resulting composite with manifold functional 
properties. Certain constituents of cellular membranes also serve as points of attachment 
for the intracellular cytoskeleton, a dynamic structure that maintains cell shape and plays a 
pivotal role in both intracellular transport (the movement of vesicles and organelles) and 
cellular division (Janmey et al., 1999; Sheetz et al., 2006). 
 
 
Figure 2.1 An electron micrograph displaying the complex internal organization of a eukaryotic 
cell. The various organelles are delimited by cellular membranes which separate these 
internal compartments from the surrounding cytoplasm. (A public domain image 
courtesy of the Dartmouth electron microscope facility) 
Biophysical Characterization of Oxidized Phospholipids 
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The two main lipid constituents of cellular membranes of eukaryotes are phospholipids 
and cholesterol. The latter is a sterol with tetracyclic ring structure, whereas the structure 
of phospholipids is based on acylated glycerol (glycerophospholipids) or sphingosine 
(phosphosphingolipids) bearing a polar headgroup, i.e. a phosphate with an attached 
alcohol moiety. Due to different combinations of headgroups together with acyl chains of 
variable length and degree of saturation, membranes of procaryotic cells typically contain 
a hundred different types of lipids. In the larger eukaryotes this number is estimated at 
>1000, making lipids the most diverse class of biomolecules (Kinnunen, 1991, Sud et al., 
2007). Interestingly, the distinct molecular compositions of cellular membranes display 
considerable variation with respect to the abundance of individual lipid species as well as 
their lateral and transversal distribution. For instance, sphingomyelins and cholesterol are 
enriched in the plasma membrane, whereas membranes of intracellular organelles have 
generally a low content of these lipids (Zambrano et al., 1975; Spector and Yorek, 1985). 
Further, in mitochondria the cholesterol fraction is mostly associated with the outer 
membrane, while the inner membrane is characterized by a high content of cardiolipin 
(Comte et al., 1976). The distribution of lipid molecules between the intra- and 
extracellular leaflets of most cellular membranes is asymmetric and actively maintained 
by ATP-dependent mechanisms (Op den Kamp, 1979; van Meer et al., 2008). A 
particularly conspicuous example of the above is provided by the phospholipids bearing 
anionic phosphatidylserine headgroups, which are excluded from the exofacial leaflet of 
the plasma membrane thereby rendering it electrically polarized (Balasubramanian and 
Schroit, 2003). In contrast, phosphatidylcholines and sphingomyelins reside 
predominantly in the outer membrane leaflet (Devaux, 1991). Finally, there is converging 
experimental evidence indicating that asymmetric distribution applies also to cholesterol 
(Hale and Schroeder, 1982; Mondal et al., 2009).  
Lateral segregation of lipids into defined clusters whose molecular composition and 
physical properties differ from those of the membrane bulk is readily observed in model 
systems and can be induced by several physical mechanisms (Mouritsen and Kinnunen, 
1996; Bagatolli, 2003), as well as through the activity of hydrolytic enzymes such as 
phospholipase A2 (Burack et al., 1993). These lipid domains represent transient and 
fluctuating surface patterns whose size and lifetime are governed by the nature of the 
cooperative interactions between the membrane constituents (Mouritsen and Jørgensen, 
1994). Accordingly, their stability is highly susceptible to modulation by proteins and 
other membrane active compounds and factors such as the membrane sterol content and 
the degree of phospholipid unsaturation (Mukherjee and Maxfield, 2004). Although our 
understanding of the functional organization of the membranes of living cells is lacking, 
an increasing number of studies have implicated lipid domains in a number of processes 
associated with cellular surfaces, including cell signaling, molecular trafficking as well as 
a variety of host-pathogen interactions (Laude and Prior, 2004). In particular, membrane 
lateral heterogeneity in the form of enigmatic lipid “rafts” containing high levels of 
sphingolipids and cholesterol has received increasing attention in recent years (Simons 
and Ikonen, 1997; Ranjendran and Simons, 2005; Michel and Bakovic, 2007. Based on 
their putative chemical composition, these specialized nanoclusters are hypothesized to 
represent areas of increased acyl chain order and to localize mainly on the exoplasmic 
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leaflet recruiting certain proteins and lipid signaling molecules (Simons and Ikonen, 1997; 
Kobouridis, 2006; Foster and Chan, 2007). Importantly, albeit raft-like supramolecular 
entities are readily produced in biomimetic model systems due various factors, no 
unambiguous direct evidence regarding the existence of physiologically relevant 
nanoscale membrane domains in vivo has been forwarded due to current technical 
limitations in probing the small-scale organization of membranes (Heerklotz, 2002; 
Lichtenberg et al., 2005; Lagerholm et al., 2005; Jacobson et al., 2007). 
Unraveling the functional significance of the considerable degree of membrane static 
and dynamic microheterogeneity introduced above represents one of the key open issues 
in  the  study  of  biological  membranes.  Yet,  the  role  of  membrane  lipid  composition  as  a  
powerful control element in determining the proper localization and functionality of 
membrane associating proteins is well established (Marsh and Horváth, 1998; Janmey and 
Kinnunen, 2006; Hunte and Richers, 2008). Along these lines, the varying chemical 
compositions as well as the various modes of nonuniform transversal and lateral molecular 
organization of cellular membranes are increasingly recognized to correspond to different 
functional states of the membrane composites.  
2.1.2 Model membranes 
The inherent structural complexity of biomembranes of natural origins represents a great 
challenge for experimental membrane science, particularly when biophysical approach 
relying heavily on techniques probing their nanoscale organization is chosen. Accordingly, 
the use of suitable simplified model systems followed by careful extrapolation of the 
experimental data is necessary in order to assess the functional properties of more intricate 
and chemically heterogeneous supramolecular assemblies. Several model membrane 
systems, each with their own merits as well as limitations, have been utilized to tackle the 
above issue (Chan and Boxer, 2007). Of these, the two most commonly used and 
thoroughly characterized are lamellar membrane vesicles (liposomes) and monomolecular 
films spread on air-water interface. 
Liposomes  
Liposomes (Fig. 2.2, A) are artificial lamellar lipid vesicles that enclose an intravesicular 
aqueous compartment (Bangham et al., 1965). They are readily prepared by exposing a 
dried lipid film to water, resulting in a population of so-called multilamellar vesicles 
(MLVs) comprising a series of concentric lipid bilayers spaced from one another by 
aqueous solution in a structure somewhat resembling an onion. In many applications 
liposomes made up by a single bilayer together with a more homogeneous vesicle size 
distribution are desired. To this end, suspension of MLVs can be further processed by 
ultrasonication or subjecting it to extrusion through polycarbonate filters, yielding small 
unilamellar (SUVs, ? < 50 nm) and large unilamellar vesicles (LUVs, ??? 50 - 200 nm), 
respectively. Yet another class of liposomes commonly encountered in literature is giant 
Biophysical Characterization of Oxidized Phospholipids 
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unilamellar vesicles (GUVs) with diameters typically ranging from 5 to 200 ?m. The large 
size of GUVs offers two major assets. First, individual liposomes doped with fluorescent 
tracers can be observed using epifluorescence microscopy allowing for direct visualization 
of molecular events such as protein binding or activity of lipolytic enzymes (Nurminen et 
al., 2002; Doeven et al., 2005); second, compared to smaller vesicles, GUVs represent a 
more cytomimetic model system since their micrometer scale corresponds to that of actual 
cells, effectively resolving certain ambiguities arising from differences in e.g. membrane 
curvature (Menger and Keiper, 1998; Holopainen et al., 2003). 
 
 
Figure 2.2 (A) Cross section of a unilamellar liposome. (B) A schematic illustration of a surface 
barostat with a phospholipid monolayer residing on the air-water interface.   
Monolayers  
Certain marked advantages over liposomes in the study of structure/function relationships 
of  membranes  are  gained  upon  the  use  of  monomolecular  lipid  films  grafted  to  the  air-
water interface. Accordingly, sample lipid composition can be precisely controlled, lateral 
packing of the molecules is readily regulated, and the area exposed to the aqueous phase is 
exactly known (Brockman, 1999). Characteristically for amphiphilic compounds, 
phospholipids form an oriented one-molecule thick insoluble layer when spread onto an 
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aqueous subphase in evaporating organic solvent. Acting as surfactants, the lipids 
adsorbing at the interface reduce the surface tension between air and the subphase. In 
these  so-called  Langmuir  monolayers  (Langmuir,  1917)  the  polar  portions  of  the  
molecules remain in contact with the aqueous phase while the hydrocarbon chains extend 
into the surrounding air (Fig. 2.2, B). A set of moving barriers can be used to compress or 
expand the monolayer and hence modify its surface area in a Langmuir trough. If the 
surface tension of the interface is measured during film compression with a high-precision 
microbalance, a compression isotherm is obtained. This allows for the assessment of the 
intermolecular interactions affecting lipid lateral packing in response to the diminished 
interfacial area per molecule (Kaganer et al., 1999; Brown and Brockman, 2007). 
Concomitantly, the electrical properties of the monolayer can be studied in the form of 
surface dipole potential, yielding information regarding the conformation and orientation 
of the monolayer constituents (Smaby and Brockman, 1990; Brockman, 1994).  
2.1.3 Physical properties and phase behavior of phospholipid aggregates 
Self-assembly 
Due to the chemical nature of the H2O molecule, the structure of liquid water is 
characterized by a dense and cooperative hydrogen bonding network (Head-Gordon and 
Hura, 2002). If non-hydrogen-bond-forming molecules (e.g. hydrocarbons) are solubilized 
in water they tend to break up this network effectively by diminishing the number of 
configurations water molecules may adopt close to the solutes. The loss of configurational 
entropy can be minimized by forcing the nonpolar molecules to cluster together thus 
maximizing the amount of free water. This so-called hydrophobic effect is the reason why 
macroscopic phase separation occurs in mixtures of water and hydrocarbons (Hiemenz 
and Rajagopalan, 1997). The hydrophobic effect acts also in aqueous solutions of 
phospholipids and other amphiphiles bearing chemical groups which markedly differ in 
their affinity for water. It provides the principal driving force underlying their 
thermodynamically arrested phase separation manifested as self-assembly into 
microscopic aggregates (mesophases) (Jones, 2002). In addition, for such systems the free 
energy minimum corresponding to a certain well-defined structure is profoundly affected 
by the organization of the hydrophilic parts of the molecules which prefer to stay in 
contact with the surrounding water. Some insight into the factors which determine what 
kind of aggregate is formed by a given phospholipid is obtained from a simple geometrical 
argument coined as the packing parameter p (Israelachvili et al., 1980). In this approach, a 
phospholipid molecule is characterized by three parameters: the optimum headgroup area 
a0, the critical chain length lc, and the hydrocarbon volume v. Using the above, the packing 
parameter is defined as p = v /  (a0 ? lc).  The hydrocarbon volume is simply the van der 
Waals volume of the hydrocarbon chain(s), while the critical chain length is equal to the 
length of the chain(s) in their fully extended configuration. The value of the optimum 
headgroup area a0 arises from a balance between two opposing forces. Accordingly, if the 
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headgroups reside too far apart, water influx to the vicinity of the hydrophobic acyl chains 
results in the increase of interfacial energy. On the other hand, too tightly packed 
headgroups will repel each other by steric and electrostatic interactions. Molecules with 
overall conical shape (i.e. p < 0.5) possess large headgroups in comparison to the area 
occupied by the acyl chains and tend to form conventional spherical or various rod-like or 
discoidal micellar assemblies. A value of p close to unity corresponds to roughly 
cylindrical molecular shape and indicates the molecules to favor lamellar structures, such 
as bilayers. Finally, inverted and hexagonal phases are formed by molecules with p > 1. 
Notably, by influencing the delicate balance between attractive and repulsive forces, 
modification of the optimum headgroup area (and hence p) can be accomplished. As 
examples, factors such as the extend of hydration of the headgroups and the range of 
electrostatic forces are amenable to tuning by osmolytes (Lehtonen and Kinnunen, 1995; 
Kinnunen, 2000) and solvent ionic strength (Cevc, 1990; Ryhänen et al., 2005), 
respectively.   
Membrane phase transitions within lamellar symmetry  
The phase behavior and phase transitions of lipids in different model systems have been a 
subject of intense investigation in the past decades (Kinnunen and Laggner, 1991; 
Alakoskela and Kinnunen, 2004). At first glance, this may seem somewhat paradoxical 
since it is well established that biologically the most important lipid phase is the lamellar 
and fluid phase (Kinnunen, 1991). Nevertheless, efforts aimed at unraveling the molecular 
level phenomena associated with various lyotropic and thermotropic phase transitions 
have provided a wealth of information on the physical properties of various types of 
membrane alloys as well as their often exceedingly complex phase behavior in aqueous 
solutions (Tate et al., 1991; Nagle and Tristram-Nagle, 2000). Further, as the salient 
physical principles governing the short and long range membrane lateral organization are 
universal, the information obtained from these studies has been of fundamental importance 
in facilitating the development of novel conceptual frameworks for understanding the 
structure and dynamics of cellular membranes.  
Lamellar lipid bilayers display a series of thermotropic phase transitions without a 
change in morphology. At lower temperatures the membrane exists at an ordered 
crystalline-like gel state (L?). Here, the transition to relatively disordered fluid-like state 
(L?) is driven by the abrupt entropy gain arising from the augmented trans?  gauche acyl 
chain conformational isomerism occurring at a temperature (Tm) characterized by a 
maximum in the heat capacity of the system. This so-called main phase transition is 
further accompanied by greatly increased rate and extent of molecular motions, manifested 
as a considerable decrease in bilayer thickness and a substantial area expansion due to 
more orientationally disordered state of the acyl chains upon exceeding Tm (Heimburg, 
1998). As a result, the penetration of water molecules into the membrane interior is 
facilitated and the van der Waals interactions between acyl chains weakened upon entering 
the L? phase.  
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Intriguingly, certain bulk physical properties of single component membranes are 
known to exhibit anomalies in the vicinity of Tm (Nagle  and  Scott,  1978;  Hønger  et  al.,  
1994; Alakoskela and Kinnunen, 2001). Several of these features have been suggested to 
be connected to the presence of two coexisting phases in the transition region, i.e. the 
presence of fluid and gel microdomains together with their interfacial boundary and 
associated strong compositional fluctuations (Freire and Biltonen, 1978; Kharakoz et al., 
1993; Kharakoz and Shlyapnikova, 2000; Metso et al., 2003). These issues are further 
emphasized when more physiologically relevant systems composed of a mixture of 
chemically distinct lipid molecules are considered, resulting in more complex phase 
coexistence over a wide range of temperatures (Almeida et al., 1993; Mouritsen and 
Kinnunen, 1996; de Almeida et al., 2003). Importantly, this highly dynamic lateral 
architecture as well as related non-equilibrium phenomena may have also interesting 
physiological implications since they render biological membranes amenable to transient 
modulation by both endo- and exogenous factors provided by the cell and its environment, 
respectively (Sperotto et al., 1989; Mouritsen, 2005).  
Lateral and transverse forces in bilayers 
In a lipid bilayer in global equilibrium the sum of forces acting in the plane of the 
structure  is  essentially  zero.  Yet,  the  free  energy  minimum  that  defines  the  equilibrium  
derives from the compromise between two opposing forces, viz. the interfacial tension (i.e. 
negative pressure) and positive pressures arising from chain conformational entropy 
together with headgroup repulsions. The magnitude of the above contributions to the total 
lateral pressure will in general depend on the distance into the center of the bilayer leading 
to a nonuniform lateral pressure profile which is further fine-tuned by factors including 
membrane molecular composition (e.g. acyl chain unsaturation and sterol content) and 
curvature (Cantor, 1999a; Patra, 2005; Ollila et al., 2007). This has important implications 
with respect to function of intrinsic membrane proteins since the individual pressure 
components may reach levels which readily induce protein conformational changes 
(Cantor, 1997a; 1999b). Hence, modulation of the lateral pressure profile constitutes an 
intriguing putative mechanism for allosteric modulation of protein conformational 
equilibria by lipid membranes, as well as membrane associating compounds such as 
general anesthetics and amphiphilic peptides inducing lateral stresses within the 
membrane (Cantor, 1997b).  
Transmembrane proteins consist of a hydrophobic anchor residing within the 
membrane core together with water-soluble segments that protrude into the extracellular 
or intracellular space. Since it is energetically unfavourable to expose the hydrophobic 
regions of these proteins to the aqueous phase outside the membrane, their hydrophobic 
contours must closely match the length of the acyl chains of the lipids constituting the 
membrane matrix. This can be brought about by proper alignment of the protein tilt angle 
within the membrane matrix or by adjustments in the thickness of the membrane to fit 
around the protein (Lee, 2003). As a general rule, membrane thickness is determined by 
the hydrophobic length of its lipid constituents. Accordingly, in order to abolish the 
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hydrophobic mismatch and to better accommodate membrane-spanning proteins whose 
hydrophobic length differs from membrane thickness, stretching or compression of the 
neighbouring lipids has to take place with corresponding changes in their interfacial cross-
sectional area (Janmey and Kinnunen, 2006). These deformations generate packing 
disorders that increase membrane elastic energy, which may subsequently influence the 
insertion and conformational balance of transmembrane proteins as well as induce 
membrane-mediated protein-protein interactions (Killian, 1998; Marsh, 2008).  
2.2 Reactive oxygen species and phospholipid oxidation 
It is well established that O2, the common allotrope of elemental oxygen, is detrimental to 
all forms of life (Halliwell and Gutteridge, 2007). It is particularly toxic to anaerobic 
organisms such as Bacteroides and Clostridium species that will thrive only in niches 
where oxygen is absent or present in reduced amounts compared to atmospheric level of 
21%. As an evolutionary trait, organisms with oxygen based metabolism (aerobes) have 
developed protective mechanisms in order to shield essential cellular components from 
oxidation and to preserve the redox homeostasis within their cells. These antioxidant 
defenses include both endogenous and diet derived molecules that can be further 
categorized as enzymatic or nonenzymatic (Sies, 1997). Notably, due to the constant flux 
of reactive species arising from cellular metabolism the antioxidant capability of an 
aerobic organism is seldom sufficient to detoxify all oxidizing agents, resulting in damage 
to  DNA,  proteins,  lipids  as  well  as  other  macromolecules  also  under  ambient  O2 levels 
(Davies, 1995; Sayre et al., 2001).  
By definition, the ground state of the diatomic oxygen molecule can be considered as a 
free radical due to its two unpaired electrons, each located in a different ?* antibonding 
orbital. Hence molecular oxygen can act as an oxidizing agent, albeit it reacts generally 
slowly with most non-radicals since according to Pauli’s principle it has to accept 
electrons one at a time. Yet, absorption of energy in the form of infrared radiation can lead 
to generation of metastable and more reactive forms of O2. Of these, singlet oxygen 
(1?gO2) is not a radical since it does not possess unpaired electrons. The 1?g electronic 
state effectively abolishes the above spin restriction enhancing the oxidizing capability of 
the molecule considerably. In biological systems singlet oxygen is often produced by 
photosensitization reactions following illumination of molecules such as riboflavin and 
porphyrins and subsequent collision-induced transfer of excitation energy to an adjacent 
ground state O2 molecule (Ochsner, 1997; Schweitzer and Schmidt, 2003). Other reactive 
oxygen species (ROS) are produced upon reduction of oxygen, whereupon the arriving 
electrons are first accommodated to the ?* antibonding orbitals of a ground state O2 
molecule. Accordingly, one-electron reduction of O2 yields superoxide radical, •O2-. 
Addition of another electron to •O2- will give O22-, a non-radical peroxide ion with paired 
electrons on both ?* orbitals. If two more electrons are subsequently added, the oxygen-
oxygen bond is deleted yielding two oxide ions (O2-). Generally in biological systems the 
two electron reduction product of O2 is hydrogen peroxide (H2O2) and the four-electron 
product water, i.e. protonated O22- and O2-, respectively. 
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Cellular redox homeostasis is a subtle equilibrium between the rate and magnitude of 
oxidant formation and the rate of their elimination. Oxidative metabolism imposes a 
potential threat to cells because of the associated formation of ROS (Fridovich, 1986; 
Karihtala and Soini, 2007, Ryter et al., 2007). In addition to above introduced singlet 
oxygen, •O2-, O22-, and H2O2, common ROS include hydroxyl (•OH), peroxyl (ROO•), and 
alkoxyl (RO•) radicals as well as peroxynitrite (ONOO-) and organic hydroperoxides 
(ROOH). Although the main source of ROS in vivo is the leakage of partially reduced 
oxygen during mitochondrial respiration, they are also produced by peroxisomal ?-
oxidation of fatty acids, microsomal cytochrome P450 metabolism of xenobiotic 
compounds, activated phagocytes, arginine metabolism, and a number of tissue specific 
enzymes (Halliwell and Gutteridge, 2007). Under normal conditions, most ROS are 
cleared from the cell by the collaborative activity of superoxide dismutase, catalase, and 
glutathione peroxidase together with small antioxidant molecules such as ascorbate 
(vitamin C) and membrane associated ?-tocopherol (vitamin E) (Matés et al., 1999; 
Chaudière and Ferrari-Iliou, 1999; Vernet et al., 2004). Yet, a state coined oxidative stress 
may  be  imposed  on  cells  as  a  result  of  one  of  two  factors:  (i)  an  increase  in  ROS  
generation or (ii) diminished antioxidant capability. Also the inability to repair oxidative 
damage may contribute to the severeness of oxidative stress experienced by a given 
organism. Accordingly, oxidative stress can be defined as a state where the overproduction 
of oxidants overwhelms the cellular antioxidant defense network (Halliwell and 
Gutteridge, 2007).  
It is important to keep in mind that besides mediating above described deleterious 
effects, (controlled) generation of ROS has also essential and beneficial roles in cellular 
physiology. They are produced by inflammatory cells for killing invading microorganisms 
in a nonspecific manner, thereby making it difficult for the pathogens to develop 
resistance through mutations affecting a single molecular target (Forman and Thomas, 
1986; Nathan and Shiloh, 2000). ROS are also used in cell signaling to regulate the 
activity of enzymes and transcription factors (Irani et al., 1997; Forman and Torres, 2001). 
Like phosphorylation, this so-called redox signaling is based on covalent modification of 
the target molecules causing them to become activated or deactivated (Blanchetot et al., 
2002; Meng et al., 2002). 
2.2.1 The sources of oxidized phospholipids 
The cellular membranes of eukaryotes contain large amounts of  
diacylglycerophospholipids that are prone to oxidative modification due to the high 
prevalence of polyunsaturated fatty acid (PUFA) tails (Hauser and Poupart, 1992). 
Common PUFAs in vivo include arachidonic (AA) and linoleic (LA) acids as well as long 
chain fatty acids such as docosahexaenoic acid (DHA) frequently linked to the sn-2 
position of the glycerol backbone of a phospholipid molecule. Nonenzymatic membrane 
oxidative damage follows from lipid peroxidation proceeding as a chain reaction that 
includes the three discrete phases of initiation, propagation, and termination (Dix and 
Aikens, 1993; Niki et al., 2005). Initiation occurs characteristically upon abstraction of a 
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labile bis-allylic hydrogen from a PUFA (LH) by a suitable ROS yielding a carbon-
centered lipid radical (L•) that subsequently undergoes a molecular rearrangement to a 
resonance-stabilized conjugated diene (Fig 2.3). Under aerobic conditions diffusion-
controlled addition of O2 will generate a lipid peroxyl radical (LOO•), the chain carrying 
species of peroxidation. Peroxyl radicals can abstract a bis-allylic hydrogen from an 
adjacent lipid molecule to generate concomitantly a new LOO• and a lipid hydroperoxide 
(LOOH). This propagation cycle eventually results in the net conversion of lipids to 
LOOHs. Alternatively, lipid hydroperoxides may be directly formed through oxidation of 
a PUFA with singlet oxygen (Girotti, 1998). Termination of lipid peroxidation is most 
often achieved by the reaction of two peroxyl radicals to form nonradical products or the 
encounter  of  one  LOO•  with  a  terminating  radical  (or  a  free  radical  inhibitor,  AH)  to  
generate noninitiating and nonpropagating radical species, which then self-quench by 
diverse pathways (Dix and Aikens, 1993). Interestingly, in the absence of antioxidants or 
other ”chain-breaking” molecules, lipid peroxidation displays the peculiar phenomenon of 
so-called inverse dose rate behavior (Stark, 2005). Accordingly, high production rates of 
ROS which initiate lipid peroxidation yield a smaller amount of reactive end-products 
than low production rates at equal dose of the initiating species. This is a consequence of 
the radical chain mechanism underlying lipid peroxidation, since the contribution of the 
bimolecular radical-radical termination reaction increases with the second power of the 
LOO• concentration thereby decreasing the kinetic chain length (i.e. the number of LOOH 
formed per initiating radical). 
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Figure 2.3 A general scheme of autocatalytic oxidation of unsaturated lipids. See text for details. 
Phospholipids with sn-2 fatty acid hydroperoxides are readily reduced into 
corresponding hydrodienes. Decomposition of the latter is a common reaction leading to a 
immensely complex mixture of products including low molecular weight aldehydes such 
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as malondialdehyde (MDA) and 4-hydroxy-2-trans-nonenal (HNE) together with a 
plethora of oxidatively modified truncated sn-2 acyl chains attached to the parent lipid 
molecule. The possible chemical structures of the resulting oxidized chains are dictated by 
the nature of the oxidized substrate (viz. chain length and degree of unsaturation) and the 
prevailing chemical environment, yet they typically bear terminal aldehyde or carboxyl 
groups as well as other polar functional groups along the length of the chain (Fruhwirth et 
al., 2007). In addition, chemically more complex cyclic derivatives including 
isoprostaglandins, isolevuglandins, and isothromboxans are also generated in considerable 
amounts from PUFA precursors through complex molecular rearrangements involving 
unstable endoperoxide intermediates (Roberts and Morrow, 2002).   
Oxidized lipid fractions isolated from biological samples are commonly racemic, 
suggesting that most oxidized derivatives are formed as a result of nonenzymatic reactions 
(Fruhwirth et al., 2007). Nevertheless, oxidation following the activity of specific 
enzymatic pathways represents an important source of oxidized lipids. Enzymes 
commonly associated with the generation of lipid oxidation products include iron-
containing lipoxygenases, which catalyse the peroxidation of free fatty acids (Brash, 
1999), as well as the ROS producing myeloperoxidase and NADPH oxidase involved in 
innate immunity defense and activated during the respiratory burst of neutrophils in 
response to invading microorganisms (Hampton et al., 1998).  
2.2.2 Bioactivity and physiological impact of phospholipid oxidation 
products 
Accumulation of oxidation products of unsaturated phospholipids is readily expected to 
perturb the structure of the lipid matrix of cellular membranes because their polarity and 
effective molecular shape (i.e. the packing parameter) may differ significantly from those 
of their parent molecules. Importantly, such modifications are likely to alter the chemical 
and physical environment of membrane associated biological macromolecules, thus 
indirectly modulating their conformation and functionality. 
Lipid oxidation has been demonstrated to increase the permeability of bilayers to water 
molecules both experimentally (Nakazawa et al., 1986) and by molecular dynamics 
simulations (Wong-ekkabut et al., 2007). Membrane thinning following free radical-
mediated oxidation has also been observed by small-angle x-ray diffraction (Mason et al., 
1997). Effect of oxidation on phospholipid acyl chain dynamics was studied in SUVs by 
measuring the time-resolved fluorescence anisotropy of incorporated diphenylhexatriene 
(DPH) -labeled lipid derivative (Borst et al., 2000). Higher anisotropy of DPH emission 
was observed with increasing mole fraction of the oxidized lipid component suggesting 
augmented acyl chain order in oxidized membranes, possibly reflecting the decreased 
extent  of  lipid  unsaturation  due  to  loss  of  double  bonds.  Notably,  the  above  effect  was  
more prominent in samples containing ? 50 mole percent of oxidized lipids, whereas 
below this level only a minor increase in anisotropy was evident when compared to a non-
oxidized control. Further, in the same study the diffusion-controlled excimer formation 
capability of pyrene-labeled lipid derivatives was utilized to demonstrate that the lateral 
Biophysical Characterization of Oxidized Phospholipids 
 
 
 
 
28 
mobility of phospholipids is hindered following membrane oxidative damage. Somewhat 
conflicting results were obtained in a series of EPR spectroscopy studies of supported 
phospholipid bilayers containing variable amounts of oxidized lipids of both synthetic and 
natural origins. A progressive loss of EPR spectral anisotropy of enclosed nitroxide spin 
labels was observed to accompany an increase in the content of oxidized lipids in the 
membrane (Megli and Sabatini, 2003a; 2003b; 2004). This loss of anisotropy was 
attributed to the decrease in acyl chain order caused by the presence of phospholipid 
oxidation products. In addition, EPR studies have revealed nonhomogeneous lateral 
mixing of membrane components in MLVs composed of variable ternary mixtures of 
saturated dipalmitoylphosphatidylcholine (DPPC) together with both oxidized and 
unoxidized 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphatidylcholine (PLPC). More 
specifically, the presence of oxidized PLPC induced temperature-reversible phase 
separation in the more densely packed DPPC-rich membranes, whereas homogeneous 
lipid mixing was evident in more ”fluid” PLPC-rich vesicles (Megli et al., 2005). 
Numerous molecular species generated upon phospholipid oxidation contain 
chemically reactive groups such as aldehyde and keto carbonyls, epoxides, and double 
bonds conjugated to carbonyl groups (Fruhwirth et al., 2007). Consequently, under proper 
conditions oxidized phospholipids or their fragments may form covalent adducts with 
manifold cellular constituents containing nucleophilic functional groups, thereby affecting 
their structure and function (Hörkkö et al., 1999; Chen et al., 2006; Catalá, 2009). A 
characteristic property of aldehydes is the ability to create Schiff bases with primary 
amino groups of biomolecules such as proteins (Ahmed et al., 2003; Sayre et al., 2006) 
and amino phospholipids, including phosphatidylethanolamines (Guichardant et al., 1998). 
?-Hydroxyalkenals, common secondary products of lipid peroxidation, constitute a class 
of particularly reactive lipid aldehydes due to a terminal ?-oxygenated-???-unsaturated 
carbonyl group. Along with Schiff base formation, they readily undergo the addition of 
thiol or amine nucleophiles to their highly electrophilic ?-carbon atoms (the so-called 
Michael addition). Notably, also preformed Schiff base protein adducts of ?-
hydroxyalkenals may undergo subsequent Michael additions generating high molecular 
weight protein-protein cross-links (Fruhwirth et al., 2007). Finally, both Schiff bases and 
Michael adducts of ?-hydroxyalkenals with proteins are susceptible to intramolecular 
cyclization reactions yielding pyrroles and cyclic hemiacetals, respectively (Fruhwirth et 
al., 2007). 
There is a growing body of evidence implicating oxidatively modified phospholipids 
in receptor-mediated cellular signaling pathways and molecular recognition events. Over 
the past several years, various products of phospholipid oxidation possessing specific 
structural elements have been recognized as high-affinity ligands for pattern-recognition 
receptors (PRRs) including scavenger receptors (Nicholson et al., 1995) and Toll-like 
receptors (Walton et al., 2003). These highly conserved transmembrane receptors are 
expressed in macrophages and other cell types participating in the recognition of 
pathogen-associated molecular patterns as well as apoptotic and senescent cells and 
oxidatively modified lipoproteins (Greenberg et al., 2006). Accordingly, they constitute an 
important part of the innate immunity system in surveying tissues for invading pathogens 
and endogenous entities destined for removal through phagocytosis. Much of the current 
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knowledge regarding the role oxidized phospholids as PRR ligands stems from the studies 
of their interaction with the multiligand macrophage scavenger receptor CD36, which 
mediates the uptake of oxidized lipoproteins eventually leading to cholesterol buildup and 
formation of macrophage foam cells (Podrez et al., 2002b). The CD36 binding activity of 
oxidized lipoproteins has been demonstrated to reside within the organic solvent soluble 
(i.e. lipid) fraction (Boullier et al., 2000), and subsequently the molecular structures of the 
oxidized phospholipid ligands were identified in a systematic study using a combination 
of chromatographic and mass spectrometric techniques (Podrez et al., 2002a; 2002b). The 
salient role for CD36 in binding of oxidized phospholipids is further corroborated by 
findings indicating macrophages of knockout mice lacking functional CD36 to exhibit 
diminished uptake of oxidized low density lipoprotein particles and foam cell formation 
(Rahaman et al., 2006). Interestingly, CD36 has also been suggested to trigger the 
identification and subsequent engulfment of apoptotic cells by macrophages (Greenberg et 
al., 2006). It is generally assumed that apoptotic cells are recognized by CD36 following 
specific binding to phospholipids with anionic phosphatidylserine headgroups externalized 
to the outer leaflet of the plasma membrane during execution of the programmed cell 
death (Fadok et al., 1992; 2000; Rigotti et al., 1995). Yet, this paradigm has to be 
reevaluated in the light of experimental evidence suggesting that the presence of 
oxidatively modified phosphatidylserines in the outer leaflet facilitates phagocytosis of 
both viable and apoptotic cells, whereas their nonoxidized counterparts lack this capacity 
(Greenberg et al., 2006). Further, preferential peroxidation of phosphatidylserines by 
redox-active cytochrome c (cyt c) released from mitochondria has been demonstrated to 
follow various proapoptotic stimuli (Kagan et al., 2003). These oxidative modifications 
were observed to correlate with enhanced phosphatidylserine externalization from the 
cytoplasmic leaflet by promoting spontaneous flip-flop, or alternatively, by altering 
aminophospholipid translocase activity (Fabisiak et al., 1997; Jiang et al., 2003; Kagan et 
al., 2003). Hence, it seems plausible that the specific epitopes on apoptotic cells binding to 
CD36 are represented by oxidized phosphatidylserines residing on the cellular surface, and 
the role of its anionic headgroup is to mediate electrostatic binding to cyt c with a positive 
net charge resulting in specific peroxidation of this phospholipid species and its 
subsequent externalization.  
2.2.3 The role of phospholipid oxidation in human pathophysiology 
Bioactive products of phospholipid oxidation have been implicated as endogenous factors 
in the development of various degenerative disorders (Halliwell and Gutteridge, 1990; 
Mahadik and Mukherjee, 1996; Berliner et al., 2001; Butterfield and Lauderback, 2002). 
They accumulate in cellular membranes and lipoprotein particles following oxidative 
stress associated disturbances in normal cellular redox homeostasis and are also generated 
in increased amounts in apoptotic and necrotic cells (Chang et al., 2004; Berliner and 
Gharavi, 2008). In particular, there is a general consensus regarding the role of 
endogenous oxidized phospholipids in promotion of atherosclerosis, a chronic 
inflammatory condition characterized by lipid accumulation and monocyte infiltration into 
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the subendothelial space of the vascular wall. Considerable in vitro and in vivo evidence 
link oxidized phospholipids to all stages of atherogenesis, from the initial fatty streaks to 
thrombosis (Berliner et al., 2001; Berliner and Watson, 2005). The varying atherogenic 
properties of individual oxidatively modified phospholipid species are strongly influenced 
by the chemical nature of their truncated sn-2 chains and may reflect, in part, the 
capabilities of these molecules to act as specific mediators stimulating adhesion of 
monocytes to the vascular endothelium and production of potent chemokines such as 
monocyte chemoattractant protein 1 (MCP-1) and interleukin 8 (IL-8) by the endothelial 
cells through the activation of mitogen-activated protein kinases (MAP-kinases) and the 
Jak/STAT pathway (Furnkranz et al., 2005; Gharavi et al., 2007). In addition, certain 
oxidized phospholipids isolated from atherosclerotic plaques have been recognized as 
modulators of gene expression leading to phenotype switching of smooth-muscle cells of 
vessel walls to an inflammatory state (Pidkovka et al., 2007). Formation of foam cells in 
the subendothelial space is increased following differentiation of monocytes into 
macrophages and their subsequent uptake of oxidized low density lipoproteins via CD36 
mediated mechanism, as described in the previous section. Concomitantly, the 
inflammatory  process  is  sustained  as  a  result  of  the  production  of  various  ROS  and  
cytokines by these macrophages, further facilitating the generation of oxidized 
phospholipids and the recruitment of additional inflammatory cells into the atherosclerotic 
lesions, respectively. High concentrations of oxidized phospholipids amplify cell death via 
apoptosis in smooth-muscle or macrophage derived foam cells (Hajjar and Haberland, 
1997), eventually culminating in the formation of the core of atherosclerotic lesions. To 
this end, oxidized phospholipids have been demonstrated to induce apoptosis following 
increase in ceramide levels due to activation of acid sphingomyelinase through an as yet 
unresolved mechanism (Loidl et al., 2003), or by directly inducing the release of cyt c 
from mitochondria activating the intrinsic caspase cascade (Chen et al., 2007). They also 
promote  thrombosis  through  modulation  of  the  expression  and  activity  of  thrombotic  
factors (Ishii et al., 2003) and enzymes in the coagulation pathway (Ohkura et al., 2004). 
Finally, apart from their involvement in its pathogenesis, products of phospholipid 
oxidation show promise as diagnostic markers of coronary artery disease owing to the 
observed correlation between high plasma levels of LDL and lipoprotein (a) associated 
oxidized phospholipids and the incidence of cardiovascular events (Tsimikas et al., 2005; 
Kiechl et al., 2007). 
Lipid membranes have been demonstrated to enhance aggregation of various 
amyloidogenic peptides and proteins under in vitro conditions  (Choo-Smith  et  al.,  1997;  
Lee et al., 2002; Kazlauskaite et al., 2003; Knight and Miranker, 2004). Accordingly, 
partial unfolding or other more subtle conformational modifications following association 
of polypeptide chains with membrane surface or their intercalation into the acyl chain 
region may reduce transition state energy barriers on the pathway of folding towards ?-
sheet rich oligomeric intermediates and mature amyloid fibrils (Sparr et al., 2004; Zhao et 
al., 2004; Gorbenko and Kinnunen, 2006; Murphy, 2007). The key characteristics of the 
protein-lipid interactions responsible for the modulation of the assembly of amyloid fibrils 
in membrane environment are likely to be profoundly affected following oxidative 
membrane damage, resulting in altered kinetics of fibrillogenesis as well as the 
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morphology and cytotoxicity of the mature aggregates. This might have important 
implications in so-called conformational diseases in which the adoption of non-native 
conformation of a disease-specific protein leads to its progressive aggregation and 
deposition (Carrell and Lomas, 1997; Lin and Liu, 2006). Alzheimer’s disease is an age-
related incurable proteopathy characterized by extracellular accumulation of misfolded 
and aggregated fibrillar amyloid ?-proteins (A?) in specific regions of the brain (Klein et 
al., 2004; Selkoe, 2002). In the developed countries, it represents the most common form 
of dementia and is one of the most economically costly diseases to society. While the 
overall etiology and pathogenesis of Alzheimer’s remain poorly understood, there is a 
large body of evidence suggesting that the brains of the patients are under increased 
oxidative stress and this may have a role in the observed neuronal dysfunction and death 
(Marcus et al., 1998; Moreira et al., 2008; Sayre et al., 2008). Indeed, brain tissue is 
particularly susceptible to oxidative stress due to low intrinsic antioxidant defenses 
(Knight, 1998). In addition, species bearing highly oxidizible PUFAs constitute a major 
fraction of brain phospholipids (White, 1973) leading to accumulation of oxidation 
products following an imbalance between ROS production and detoxification. Based on 
the results from polarized attenuated total internal reflection Fourier-transform infrared 
spectroscopy (PATIR-FTIR) experiments, it is known that monolayers containing 
oxidatively modified phospholipids accumulate A? significantly faster from the aqueous 
subphase compared to films composed solely of unoxidized or saturated phospholipids, 
and A? adsorbed on oxidized membranes displays more complete adaptation of the 
antiparallel ?-sheet conformation characteristic for amyloid (Koppaka and Axelsen, 2000; 
Koppaka et al., 2003; Komatsu et al., 2007). In addition, it has been suggested that the 
molecular mechanism of lipid oxidation product catalyzed A? amyloidogenesis includes 
covalent modifications by soluble aldehydic fragmentation products of phospholipid 
oxidation,  most  notably  HNE.  Accordingly,  formation  of  Michael  adducts  of  HNE  with  
histidine residues was found to augment the membrane affinity of A?, possibly through 
conformational changes and increased hydrophobicity of the peptide molecules. 
Monomeric A?-HNE adducts residing on surface of nonoxidized membranes were further 
observed to facilitate adsorption and aggregation of additional unmodified A? even at 
relatively low peptide concentrations, therefore implicating them as potential molecular 
templates or nuclei for subsequent fibrillization (Liu et al., 2008). Interestingly, 
phospholipid-bound A? also facilitates ROS mediated membrane oxidative damage 
caused by physiological concentrations of ascorbate and redox-active copper ions (Murray 
et al., 2005; 2007). In the light of the above, it seems thus plausible that a mechanism of 
positive feedback between A? misfolding and lipid oxidation could have a prominent role 
in the in vivo pathogenesis of the sporadic form of Alzheimer’s.  
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3 Outline of the present study 
Interest in bioactive oxidatively modified phospholipids has been rising rapidly following 
reports establishing their involvement in pivotal physiological processes such as cellular 
signaling and apoptosis. Moreover, deeper understanding of their role as markers and 
mediators of pathophysiology is anticipated to offer opportunities for development of 
novel therapeutic and diagnostic approaches for certain chronic medical conditions, 
including neurodegenerative disorders and atherosclerosis. Yet, the molecular level impact 
of oxidized phospholipids on the architecture and function of cellular membranes remains 
largely elusive. To address this issue, three specific aims were assigned to the present 
study, as follows: 
 
(i)  To characterize alterations in the structural dynamics of biomembranes 
brought about by phospholipid oxidation using biophysical methods and 
model membranes. 
 
(ii) To evaluate, by using as model compounds three small amphiphilic 
therapeutic agents capable of triggering oxidative stress in vivo, the 
suitability of oxidized phospholipids as drug targets as well as their possible 
influence on drug distribution, pharmacokinetics, and oxidative stress-
associated clinical side effects.  
 
(iii) To investigate the effects of oxidatively modified phospholipids on the 
membrane association of antimicrobial peptides.  
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4 Materials and methods 
4.1 Materials 
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dimyristoyl-sn-glycero-3-
[phospho-rac-(1-glycerol)] (DMPG, Na+-salt), 1-palmitoyl-2-oleyl-sn-glycero-3-
phosphocholine (POPC), 1-palmitoyl-2-oleyl-sn-glycero-3-phospho-L-serine (POPS), 1-
palmitoyl-2-(9’-oxo-nonanoyl)-sn-glycero-3-phosphocholine (PoxnoPC), 1-palmitoyl-2-
azelaoyl-sn-glycero-3-phosphocholine (PazePC), 1-palmitoyl-2-lyso-sn-glycero-3-
phosphocholine (lysoPC), 1-palmitoyl-2-(N-4-nitrobenz-2-oxa-1,3-diazol)aminocaproyl-
sn-glycero-3-phosphocholine (NBD-PC) were from Avanti Polar Lipids (Alabaster, AL), 
and 1-palmitoyl-2-[10-(pyren-1-yl)decanoyl]-sn-glycero-3-phosphocholine (PPDPC) from 
K&V Bioware (Espoo, Finland). 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 
NaCl, Hepes, MES, EDTA, haloperidol, chlorpromazine, doxorubicin, calf thymus DNA, 
polyphosphate, methoxyamine hydrochloride, horse heart cytochrome c (type VI, oxidized 
form),  and  Na2-ATP  were  from  Sigma  (St.  Louis,  MO),  and  CaCl2 and DMSO from 
Merck (Darmstadt, Germany). Indolicidin was from Bachem (Bubendorf, Switzerland), 
temporin B from Synpep (Dublin, CA), and temporin L and LL-37(F27W) from Caslo 
(Lyngby, Denmark).  
The purity of the above lipids was verified by thin layer chromatography on silicic acid 
coated plates (Merck) using chloroform/methanol/water/ammonia (65:20:2:2, v/v) as the 
eluent. No impurities were detected upon examination of the plates after iodine staining. 
Stock solutions of the lipids were prepared in chloroform and stored at -20 oC. 
Concentrations of the stock solutions of nonfluorescent lipids were determined 
gravimetrically using a high-precision electrobalance (Cahn Instruments, Cerritos, CA), 
while those of NBD-PC and PPDPC were determined spectrophotometrically using the 
molar extinction coefficients ? = 21.000 cm-1 at 465 nm and ? = 42.000 cm-1 at 344 nm, 
respectively. The purity of the peptides was > 95% for indolicidin, temporin B, and LL-
37(F27W), and > 97% for temporin L as verified by high performance liquid 
chromatography analyses provided by their respective suppliers. The tryptophan mutant 
LL-37(F27W)  was  used  so  as  to  allow  the  assessment  of  its  interactions  with  model  
membranes by fluorescence spectroscopy. Importantly, this mutant has been demonstrated 
to retain essentially identical antimicrobial activity as the wild type LL-37, as verified for 
Bacillus subtilis and Staphylococcus aureus (Sood et al., 2008). Freshly deionized filtered 
water (Milli RO/Milli Q, Millipore Inc., Jaffrey, NH) was used in all experiments. 
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Figure 4.1 The chemical structures of the two oxidatively modified phospholipids used in this 
study, viz. PazePC and PoxnoPC. 
4.2 Preparation of unilamellar vesicles and lipid dispersions (II, 
III, IV) 
Appropriate amounts of lipid stock solutions were mixed in chloroform to obtain the 
desired compositions. The solvent was removed under a stream of nitrogen and the lipid 
residue was subsequently maintained under a reduced pressure for at least 2 h. 
Multilamellar vesicles (MLVs) were prepared by hydrating the dry lipid films with 
appropriate buffer at a temperature exceeding the main phase transition temperature of the 
lipid components and their mixtures. The hydrated lipid dispersions were extruded 
through a 100 nm pore size polycarbonate filter (Nucleopore, Pleasanton, CA) using a 
LiposoFast low pressure homogenizer (Avestin, Ottawa, Canada) to obtain large 
unilamellar vesicles (LUVs) with average diameter of approximately 80-100 nm as 
determined by dynamic light scattering. 
Aqueous  dispersions  of  PoxnoPC  and  PazePC  (Fig.  4.1)  as  well  as  lysoPC  were  
prepared essentially as described above, except omitting extrusion and instead placing the 
samples in a bath-type sonicator for 20 min to ensure efficient dispersion. The resulting 
suspensions remained optically clear for several days at +4 oC. During the above 
procedures minimal exposure of the lipids to light was ensured.  
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4.3 Surface tension and monolayer measurements (I, II, IV) 
4.3.1 Monolayer compression isotherms 
A computer-controlled Langmuir-type film balance (?Trough XL, Kibron, Espoo, 
Finland) equipped with a Precision Plus trough was used to simultaneously measure 
surface pressure-area (?-A) and surface potential-area (??-A)  isotherms  using  the  
embedded features of the control software (Filmware 3.52, Kibron). The indicated lipid 
mixtures were made in chloroform and spread in this solvent onto the air-aqueous phase 
(15  mM  NaCl)  interface  with  a  Hamilton  microsyringe.  The  above  subphase  was  
employed since the presence of salt decreases noise in the surface potential measurements. 
Total surface area of the trough is 120 cm2 with a subphase volume of 20 ml. After 5 min 
equilibration (to ensure evaporation of the solvent) the film compression was started using 
two  symmetrically  moving  Teflon  barriers.  Compression  rate  was  4  Å2/chain/min in all 
experiments, so as to allow for the reorientation and relaxation of the lipids in the course 
of the compression. Surface pressure was monitored with a metal alloy probe hanging 
from a high precision microbalance (KBN315, Kibron) connected to a computer, and is 
defined as 
(1)                                            ??? ?? 0  
where ?0 is the surface tension of the air-aqueous phase interface and ? is  the  value  for  
surface tension in the presence of a lipid monolayer compressed to varying packing 
densities. Monolayer surface potential ?? was measured using the vibrating plate method 
(?Spot, Kibron). All the isotherms were recorded at ambient temperature and were 
repeated at least twice to ensure reproducibility. 
Phase transitions were identified from isotherms using derivatives of surface pressure 
with respect to area. The values for monolayer isothermal compressibilities (CS) for the 
indicated film compositions at the given surface pressure were obtained from ?-A data 
using 
(2)                                  ? ? ? ?TddAAC ?? //1S ???  
where A? is the area per molecule at the indicated surface pressure ?. To identify the phase 
transition points the data was further analyzed in terms of the reciprocal isothermal 
compressibility (CS-1). Accordingly, the higher the value of CS-1, the lower the interfacial 
elasticity. 
The collected ?? versus A data  were  analyzed  in  terms  of  ??, the component of the 
monolayer dipole moment vector perpendicular to the monolayer plane. The values for ?? 
were obtained essentially as described by Brockman (1994). In short, ?? was plotted 
against 1/A and subsequently the linear regions of this curve were fitted by equation 
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(3)                                A/170.37?? 0 ??? ????  
to give an estimate of the molecular dipole moment ??. 
4.3.2 Monolayer fluorescence microscopy 
Lateral organization of mixed monolayers was observed by fluorescence microscopy 
while compressing the indicated films in the above described instrument to the given 
values of ?.  The  trough  (?TroughS, Kibron) was mounted on the stage of an inverted 
microscope (Zeiss IM35, Jena, Germany) and the quartz-glass window in the bottom of 
the trough was positioned over an extra-long working distance 20? objective (Nikon, 
Tokyo, Japan). A 450-490 nm bandpass filter was used for excitation and a 520 nm 
longpass filter for emission. Images were captured with a Peltier-cooled 12-bit digital 
camera (C4742-95, Hamamatsu Photonic, Hamamatsu, Japan) interfaced to a computer 
running image-processing software (HiPic 4.2.0) provided by the camera manufacturer. 
NBD-PC (X = 0.02) was included in the indicated lipid mixtures as a fluorescent probe. 
After equilibration the monolayers were compressed by two symmetrically moving 
barriers. All measurements were carried out at ambient temperature and repeated at least 
twice. The percentages of the monolayer in fluid and solid phases at given values of 
surface pressure were calculated from the fluorescence microscopy images using the 
program ImageJ. 
4.3.3 CMC determination 
Critical micelle concentrations (CMC), apparent molecular cross sectional areas (AS), and 
apparent air-water partitioning coefficients (Ksw) for PazePC, PoxnoPC, and lysoPC were 
determined using serial dilutions of these lipids in 20 mM Hepes, 0.1 mM EDTA, pH 7.4 
up to 48, 45, or 40 ?M lipid (lysoPC, PazePC, and PoxnoPC, respectively) made into 96-
well cuvettes. The surface tensions ? of  these  solutions  were  measured  by  the  du  Noüy  
maximum pull technique using a computer-controlled 8-channel analyzer (Delta-8, 
Kibron). Data were retrieved and analyzed using dedicated software (Delta-8 Manager, 
Kibron). In brief, Gibbs adsorption isotherm 
(4)                                            ?
??
d
d??  
was used to relate the surface excess ? to the chemical potential ? of the molecule under 
study. In dilute solutions ???? RT dln c, and thus 
(5)                                       
cd
d
RT ln
1 ?? ??  
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where c indicates concentration, T temperature, and R = 8.314 J K-1 mol-1. Apparent 
molecular interfacial cross sectional area AS can be subsequently obtained from 
(6)                                            ?AS
1
N
A ?  
where NA is Avogadro’s number. The value for CMC is determined by the intersection of 
lines fitted to the slope of the decreasing part of surface tension versus bulk concentration 
graph and the following plateau, whereas the reciprocal of the apparent air-water 
partitioning coefficient Ksw is given by extrapolating the slope to a surface tension of 72.8 
mN/m recorded for the aqueous buffer.  
4.3.4 Penetration of peptides into lipid monolayers 
Appropriate amounts of lipid stock solutions were mixed in chloroform to obtain the 
desired compositions, which were subsequently spread onto air-buffer interface in a 
magnetically stirred circular Teflon wells with a subphase volume of 1.2 ml (Multiwell 
plate,  Kibron).  Surface  pressure  was  monitored  with  a  Wilhelmy  wire  attached  to  a  
computer-controlled Langmuir-type film balance (?TroughX, Kibron) using the embedded 
features of the control software (FilmWare 3.57, Kibron). After stabilization of the applied 
monolayer to an initial value of surface pressure ?0, the peptides were injected into the 
subphase (0.3 ?M final concentration) whereafter the increment in ? (??)  due  to  their  
intercalation into the film was followed. In order to facilitate the visual inspection of the 
results of the experiments represented as ?? versus ?0, straight lines with negative slopes 
were fitted to the data sets using least-squares regression. The x-axis intercepts of the fits 
represent estimates of the critical packing pressure ?c, i.e. the maximum value of initial 
pressure at which the peptides are able to intercalate into the monolayers of given 
composition (Brockman, 1999). All measurements were performed at ambient temperature 
of ~ 23 oC. 
4.4 Fluorescence spectroscopy (II, III, IV) 
4.4.1 Steady-state fluorescence measurements 
All fluorescence measurements were conducted with a Perkin-Elmer (Foster City, CA) 
LS50B spectrofluorometer. 
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Drug-oxPL interactions  
The  binding  of  HPD,  CPZ,  and  DOX  to  PazePC  and  PoxnoPC  was  assessed  by  
monitoring the efficiency of collisional quenching of the fluorescence emission of pyrene 
containing phospholipid analog PPDPC by these molecules. Two milliliters of 25 ?M lipid 
dispersion were placed into a magnetically stirred four-window quartz cuvette in a holder 
thermostated at 25 oC with a circulating water bath. Subsequently, 2.5 ?l aliquots of 800 
?M solution (CPZ and DOX in water and HPD in DMSO) of one of the drugs were added 
and the quenching of pyrene fluorescence was observed using 5.0 nm band-passes for both 
the excitation and emission beams of 344 nm and 394 nm, respectively. Thereafter, proper 
aliquots  of  5  M  NaCl,  2  mM  DNA,  or  1  mM  POPC/POPS  (XPOPS = 0.20) LUVs were 
added to yield the indicated final concentrations. Changes in the pyrene fluorescence 
between additions were allowed to stabilize for ~ 5-20 min, whereafter the intensity value 
was recorded and subsequently corrected for sample dilution. 
Binding of cyt c to oxPLs 
The lipid binding of cyt c was assessed as described previously (Mustonen et al., 1987) by 
monitoring the distance-dependent efficiency of Förster-type resonance energy transfer 
between PPDPC and the heme group of cyt c. Two milliliters of 25 ?M PoxnoPC or 
PazePC dispersion was placed into a magnetically stirred four-window quartz cuvette 
holder thermostated at 25 oC. Subsequently, 5 ?l aliquots of 20 ?M solution of cyt c were 
added, and the quenching of pyrene monomer fluorescence by the heme of cyt c was 
observed using 5.0 nm band-passes for both the excitation and emission beams of 344 nm 
and 394 nm, respectively.. Thereafter, proper aliquots of 3 M NaCl, 10 mM CaCl2, or 100 
mM ATP were added to yield the indicated final concentrations. Changes in the 
fluorescence between additions were allowed to stabilize for approximately 1 min. The 
intensity values were corrected for sample dilution and the inner filter effect due to sample 
absorption, with the latter according to 
(7)                                ?
?
??
?
? ??
2
loganti emexobscorr
AA
II     
where Icorr stands for the corrected intensity, Iobs for the observed intensity, and Aex and 
Aem for the sample absorbances at the excitation and emission wavelengths, respectively. 
The merits as well as limitations of the use of pyrene-labeled lipids in energy transfer 
measurements have been discussed elsewhere (Kaihovaara et al., 1991). 
Association of antimicrobial peptides with model biomembranes 
Peptides were added to a suspension of LUVs (total lipid concentration of 400 mM) in 
indicated buffer maintained at 25 oC with continuous stirring in a 1 cm path length quartz 
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cuvette yielding a final concentration of 4 ?M in a total volume of 2 ml (peptide/lipid ratio 
of 1:100). After 1 h of equilibration, fluorescence emission spectra were recorded using 
excitation wavelength of 280 nm using 5.0 nm band-passes for both the excitation and 
emission beams. The obtained spectra were corrected for the contribution of light 
scattering in the presence of vesicles.  
4.4.2 Determination of drug-membrane molar partition coefficients 
The values  for  Kp were determined from the fluorescence-quenching data by the method 
described by Parry et al. (2007). In brief, increasing [drug] was titrated into a dispersion of 
PazePC, PoxnoPC, or lysoPC including the fluorescent phospholipid analog PPDPC 
whereafter fluorescence intensity values corresponding to each drug/lipid ratio were 
recorded (series 1). Subsequently, aliquots of unlabeled lipid dispersion were added and 
again the intensity values were collected (series 2). Using the cubic interpolation function 
of Matlab (The MathWorks, Natick, MA) values for [drug] that would produce identical 
values of intensity in series 2 to those measured in series 1 were obtained, assuming each 
measured intensity value (i.e. quenching efficiency) to correspond to a single mole 
fraction X of the drug in the lipid phase, defined by 
(8)                                      
? ?
? ? ? ?LK
DK
X
p2
Tp
OH ??  
where [DT] and [L] stand for the total drug and lipid concentrations, respectively. Next, the 
numerical value of Kp was retrieved by minimizing the difference between the values of X 
produced by series 1 and 2 by varying Kp. 
4.4.3 Quenching of tryptophan emission by acrylamide 
In order to reduce absorbance by acrylamide, excitation of Trp at 295 nm instead of 280 
nm was used. Proper aliquots of 3 M acrylamide solution were added to the peptide in the 
presence or absence of liposomes at a peptide/lipid molar ratio of 1:100. The fluorescence 
intensity values obtained were corrected for dilution and the scatter contribution was 
derived from acrylamide titration of a vesicle blank. The data were analyzed in terms of 
the Stern-Volmer equation 
(9)                                         ? ?QK
F
F
SV
0 1??  
where F0 and F represent the fluorescence intensities in the absence and the presence of 
the quencher Q, respectively, and KSV is the Stern-Volmer quenching constant, which is a 
measure of the quenching efficiency and proportional to the accessibility of Trp to 
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acrylamide. On the premise that acrylamide does not significally partition into the bilayer, 
the value for KSV can be considered to be a reliable reflection of the bimolecular rate 
constant for the collisional quenching of the Trp residues present in the aqueous phase. 
Accordingly, KSV is determined by the amount of non-vesicle-associated free peptide, as 
well as the fraction of the peptide residing on the surface of the bilayer.  
4.5 Dynamic light scattering (II) 
Zetasizer Nano ZS (Malvern Instruments, Malvern, UK) was used to measure DLS from 
lipid dispersions in 10 ? 10 mm disposable cuvettes. Analysis of the time dependence of 
the intensity fluctuations in light scattered by the samples arising from the Brownian 
motion yields the diffusion coefficient (D) of the lipid aggregates from which, knowing 
the  viscosity  of  the  medium (?), their hydrodynamic radius (r) can be calculated via the 
Stokes-Einstein relation: 
(10)                                             
D
Tkr ??6
B?   
In the above equation ?? ? 3.14, kB is the Boltzmann constant, and T temperature. 
Numerical analysis of the intensity autocorrelation functions in terms of particle size 
distribution was carried out with dedicated software provided by the instrument 
manufacturer. Temperature of the sample compartment was controlled by a Peltier 
element and set to 25 oC during measurements. 
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5 Results 
5.1 Interfacial properties of two oxidized phospholipids 
5.1.1 Determination of critical micelle concentrations 
Surface tension versus concentration data for aqueous dispersions of PoxnoPC and 
PazePC are depicted in figure 5.1. These data could not be properly fitted with the Gibbs 
adsorption isotherm, yielding unrealistically low values of apparent molecular interfacial 
cross sectional area AS for molecules bearing a phosphocholine headgroup with an 
interfacial area of approximately 50-60 Å2 (Crane et al., 1999) (Table 5.1). This 
discrepancy is likely to reflect the formation of soluble premicellar complexes at low 
oxPL concentrations, which has also been suggested for various gemini surfactants based 
on their ambiguous surface activity data (Rosen and Liu, 1996).  
Figure 5.1  Surface tension ? versus 
concentration of (A) PoxnoPC and (B) 
PazePC  in  20  mM  Hepes,  0.1  mM  
EDTA, pH 7.4. Experiments were 
carried out at ambient temperature of 
~ 23 oC. The data points represent the 
mean of three or four measurements 
with the respective standard 
deviations. 
 
 
 
 
In spite of the above, critical micelle concentrations as well as the air-water partitioning 
coefficients Ksw for the two oxPLs could be readily retrieved and are compiled in table 5.1. 
It  is  noteworthy  that  the  CMCs  of  the  two  oxPLs  are  approximately  10-fold  higher  
compared to unmodified diacyl phosphatidylcholines, in agreement with premicellar 
complexation which lowers the free energy of micelle formation and increases the CMC. 
Table 5.1 Surface chemical characteristics of the two oxidatively modified phospholipids 
 CMC, ?M Ksw ? 10-3, M-1 AS, Å2 (apparent) 
PazePC 18.7 202 16.0 
PoxnoPC 21.6 164 14.0 
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5.1.2 Force-area isotherms for mixed oxPL/DPPC monolayers 
Compression isotherms (Fig. 5.2, A and B) for binary mixtures of PoxnoPC and PazePC 
with DPPC reveal, with increasing XoxPL, a progressive disappearance of the characteristic 
liquid-expanded liquid-condensed (LE ? LC) phase transition observed for neat DPPC 
monolayers. Nearly complete abolishment of the transition at XoxPL = 0.4 suggests the 
films with XoxPL? ? 0.4 to be predominantly in the liquid expanded state. 
  
  
Figure 5.2 Representative 
compression isotherms for 
PoxnoPC (A) and PazePC 
(B) in mixed monolayers 
with DPPC, the mole 
fraction of the oxidized 
phospholipid (XoxPL) 
species increasing from 
left  to  right  as  0.0,  0.05,  
0.1, 0.15, 0.2, 0.25, 0.4, 
and 1.0. The given lipid 
mixtures were spread onto 
15 mM NaCl at ambient 
temperature (~ 24 oC). 
After 4 min of 
equilibration the films 
were compressed at a rate 
of  4  Å2/molecule/min. 
Panels C and D illustrate 
variations in mean 
molecular area ? versus 
XoxPL for PoxnoPC and 
PazePC, respectively, as 
binary mixtures with 
DPPC at 5 (?), 10 (?), 20 
(?),  40  (?),  and  50  (?)  
mN/m.  The  data  were  
taken from the graphs in 
panels A and B. Standard 
deviations would be 
contained within the 
symbols and were omitted 
for the sake of clarity. 
Panels E and F compile 
the values for ? versus 
elastic moduli CS-1 
calculated from panels A and B, for PoxnoPC and PazePC containing films, respectively, with  
increasing XoxPL as (a) 0.0, (b) 0.05, (c) 0.25, and (d) 1.0. Corresponding CS-1 versus XoxPL data at 5 
??), 10 (?), 20 (?), 40 (?), and 50 (?) mN/m are shown for PoxnoPC/DPPC and PazePC/DPPC 
monolayers, and were taken from the graphs illustrated in panels A and B. 
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Another distinctive feature of the isotherms recorded for binary oxPL/DPPC films is a 
novel high pressure transition, which becomes more pronounced with increasing XoxPL. 
 Isobars of mean molecular area ? versus XoxPL (Fig. 5.1 C and D) reveal both 
PoxnoPC and PazePC to induce monolayer expansion at surface pressures ??? 40 mN/m, 
this effect being more pronounced for the latter lipid. Interestingly, above the new 
transition at approximately 40 mN/m, the two oxPLs cause film condensation. However, 
analysis of the isobars reveals the condensation to be apparent only, with ? approaching 0 
upon XoxPL?  1.0. It seems thus plausible that when the binary monolayers reach a certain 
packing density during compression the oxized phospholipid fraction dissolves from the 
monolayer to the aqueous subphase. This process appears to follow first-order kinetics, 
with a sharp inflection point in ?-A isotherms, denoted here as ?s and defined as the 
critical pressure for the dissolving of the oxidized lipids into the aqueous phase.  
Monolayer compressibility modulus 
To gain additional insight into the bulk structural characteristics of the oxPL/DPPC 
monolayers,  the  compression  isotherms  were  further  analyzed  in  terms  of  their  
compressibility modulus CS-1 as a function of ? and XoxPL (Fig. 5.2, E and F). Increasing 
XoxPL dramatically decreased CS-1 for both oxidized phospholipid species, revealing 
augmented  elasticity  of  the  films.  Compressibility  data  also  disclose  the  LE  ? LC  
transition of DPPC and the high-pressure inflection point in ?-A isotherms  observed  for  
films containing oxPLs, the minima in CS-1 coinciding with the critical pressure ?s at 
surface pressures of ~ 42-44 and ~ 40-42 mN/m for PoxnoPC and PazePC, respectively 
(Fig. 5.2, E and F). The depicted graphs also illustrate the differences in compression 
isotherms for PazePC and PoxnoPC after the high-pressure inflection. More specifically, 
the shapes of ? versus CS-1 curves in the vicinity of ?s are different for the two oxPLs. For 
PazePC there is a decrease of the first shoulder and an increase of the second one, whereas 
for PoxnoPC a decrease of both shoulders is evident both below and above ?s. In both 
cases the first shoulder appears close to the collapse pressure of pure oxidized lipid and 
following the completion of the transition the values for CS-1 equal those for DPPC. CS-1 
versus XoxPL data at surfaces pressures from 5 to 50 mN/m better demonstrate the changes 
in film compressibility modulus with varying XoxPL (Fig. 5.2, G and H).  At 5 mN/m, the 
behaviors of PoxnoPC/DPPC and PazePC/DPPC films are almost identical. In contrast, at 
40  mN/m  the  compressibility  of  PazePC/DPPC  monolayers  exceeded  that  of  
PoxnoPC/DPPC for all mole fractions studied. In addition, at 40 mN/m the value of CS-1 
for PazePC/DPPC shows a local minimum at XPazePC = 0.25.   
5.1.3 Changes in the monolayer surface potential 
Surface potential-area isotherms (Fig. 5.3, A and B) for PoxnoPC/DPPC and  
PazePC/DPPC monolayers were measured to investigate the effects of the oxPLs on 
surface electrical properties of phospholipid monolayers. A shoulder in the ??-A data 
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Figure 5.3 Representative 
surface  potential  ?? 
versus ? isotherms for 
PoxnoPC/DPPC (A) and 
PazePC/DPPC (B) films. 
XoxPL increases  (top to 
bottom) as 0.0, 0.05, 0.1, 
0.15, 0.2, 0.25, 0.4, to 1.0. 
Panels C and D depict 
isobars  for  ?? versus 
XoxPL data for 
PoxnoPC/DPPC and 
PazePC/DPPC films, 
respectively, at constant 
lateral pressure of 5 (?), 
10 (?), 20 (?),  40  (?), 
and 50 (?) mN/m. Panels 
E and F show isochores of 
?? versus XoxPL for 
PoxnoPC and PazePC, 
respectively, constructed 
at constant mean 
molecular areas of 40 (?), 
45 (?), 50 (?), 55 (?), 60 
??),  70  (+),  and  80  (?) 
Å2/molecule. Also shown 
is ?? versus XoxPL for 
PoxnoPC (G) and PazePC 
(H) containing films at 
75-90 (corresponding to 
the liquid expanded 
phase) (?), 61-65 (?), and 
40-45 (?) Å2/molecule.   
 
 
 
 
coinciding with ?s and becoming more pronounced with increasing XoxPL is observed for 
both lipids in binary mixtures with DPPC. Isobars of ?? versus XoxPL (Fig. 5.3, C and D) 
indicate that the general decrement in ? is more pronounced in the case of the carboxyl 
group bearing PazePC compared to PoxnoPC containing an aldehyde function, with a 
difference of ~ 100 and ~ 45 mV between pure DPPC and pure PazePC and PoxnoPC at ? 
= 5 mN/m, respectively. ?? versus XoxPL isochores constructed at constant mean 
molecular areas demonstrate nearly linear decrease in ?? with increasing mole fraction of 
both lipid species at ? < 70 Å2/molecule (Fig. 5.3, E and F).  
Interestingly, the value for ?? of pure PoxnoPC and PazePC is independent of the 
mean molecular area, suggesting a packing density dependent reorientation of the 
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component of dipole moment vector perpendicular to the monolayer plane (??), yielding a 
nearly constant surface dipole potential during film compression. This feature is better 
illustrated by the nearly constant values of ?? measured in the liquid expanded phase (? = 
75-90 Å2/molecule) for both PoxnoPC and PazePC containing monolayers (Fig. 5.3, G 
and H). Instead, for the range 61-65 Å2/molecule there is a drastic increase in ?? at XoxPL = 
0.1-0.25 when compared to neat DPPC. At XoxPL =  1.0  the  value  of  ?? approaches zero 
indicating the dipole moment vector to be oriented parallel to the monolayer surface or the 
oxidized phospholipid dissolving from the film into the aqueous subphase. Essentially 
similar behavior is observed for the range of ? between 40 and 45 Å2/molecule, however, 
the increase in ?? between XoxPL from 0.1 to 0.25 is less pronounced. 
5.1.4 Fluorescence microscopy of the monolayers 
The impact of the oxPLs on the two-phase region of mixed monolayers with DPPC was 
analyzed by fluorescence microscopy, visualizing the lateral distribution of the LE phase 
favoring phospholipid analog NBD-PC (XNBD-PC =  0.02).  DPPC  in  the  LE  –  LC  
coexistence region reveals the presence of randomly arrayed nonfluorescent solid domains 
in a continuous fluid and fluorescent phase above surface pressure of ~ 7 mN/m (Fig. 5.4).  
 
 
Figure 5.4 Fluorescence microscopy images for PoxnoPC/DPPC (A)  and  PazePC/DPPC (B) 
monolayers as a function of XoxPL and captured at the indicated values of ? at 
ambient temperature of ~ 24 oC. All monolayers contained NBD-PC (XNBD-PC = 
0.02) as the fluorescent dye. Compression rate was 2.5 Å2/acyl chain/min and the 
subphase was 15 mM NaCl, pH 7.4. 
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The appearance of the solid domains coincides with the onset of the LE ? LC transition. 
Upon  further  compression  of  DPPC  films  the  solid  domains  grow  in  size  whereas  their  
number decreases slightly at the expense of the fluid phase. The presence of the two 
oxPLs causes drastic differences both in the size and morphology of the solid condensed 
phase domains. More specifically, the shape of the solid domains in oxPL/DPPC mixed 
monolayers is more uniform than those in neat DPPC and the domains remain stable and 
distinguishable also at high pressures of ~ 40-50 mN/m For majority compositions and 
pressures the domains observed in PoxnoPC/DPPC films are smaller and their number 
higher than for PazePC/DPPC mixtures. Further, in agreement with the gradual increase in 
surface pressure where commencement of phase transition is observed in oxPL/DPPC 
isotherms (Fig. 5.2, A and B), the domains first appear at 9-10 mN/m for XoxPL = 0.1 and 
0.2. For films with XoxPL = 0.4 no indication of phase separation is seen at ? < 16 mN/m. 
5.2 Interactions of cationic drugs and antimicrobial peptides with 
oxPL aggregates 
5.2.1 Binding of drugs to oxPLs 
Quenching by haloperidol (HPD), chlorpromazine (CPZ), and doxorubicin (DOX) of the 
fluorescence from pyrene-labeled phospholipid derivative PPDPC (XPPDPC = 0.01) 
incorporated in PoxnoPC and PazePC dispersions was observed, revealing the binding of 
these drugs to both oxPL species (Figs. 5.5, A and 5.6, A). Upon deprotonation of the 
carboxyl moiety of PazePC this lipid bears a net negative charge, thus allowing for 
electrostatic interactions with cationic drugs. In keeping with the above, all three cationic 
drugs were found to bind PazePC with a higher apparent affinity compared to zwitterionic 
PoxnoPC and an increase in ionic strength led to their partial dissociation from this lipid, 
as judged from the reversal of fluorescence quenching (RFQ) due to added NaCl (Fig. 5.5, 
B). However, the fact that considerable amounts of all three drugs remain associated with 
PazePC at [NaCl] far exceeding the physiological 150 mM suggest the involvement of 
hydrophobicity in their mutual interaction. This is substantiated by the data on these drugs 
and PoxnoPC, from which essentially no dissociation of the three compounds was 
observed  even  at  ~  0.8  M  NaCl  (Fig.  5.6,  B). Furthermore, lysoPC, which due to the 
absence of the sn-2 acyl chain bears a structural resemblance to the two oxPLs, displayed 
behavior comparable to that of PoxnoPC with respect to both drug binding and lack of 
their subsequent dissociation (data not shown). 
All three drugs have been previously demonstrated to bind with high affinity to anionic 
phospholipids (Jutila et al., 2001; Mustonen and Kinnunen, 1993). It was therefore of 
interest to observe whether they can be dissociated from the oxPLs by mixed 
phosphatidylcholine/phosphatidylserine vesicles. To this end, drugs were first titrated into 
oxPL/PPDPC dispersions. Subsequently, unlabeled phospholipid vesicles were added and 
the reversal of the quenching of PPDPC residing in the oxPL aggregates was recorded. 
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Addition of POPC/POPS (XPOPS = 0.2) LUVs into 25 ?M PazePC solution led to a slight 
dissociation of all three drugs from the latter lipid as evidenced by the reversal of 
fluorescence quenching (Fig. 5.5, C), most likely reflecting a competition between the 
carboxyl moiety of this oxPL and the anionic PS headgroup as a drug binding site. 
Unexpectedly,  for  PoxnoPC  and  HPD  and  CPZ,  the  addition  of  POPC/POPS  LUVs  
caused a further decrease in PPDPC fluorescence (Fig. 5.6, C). This could result from 
Coulombic attraction between the negatively charged PC/PS LUVs and PoxnoPC 
aggregates, the latter bearing a positive net charge because of the bound cationic drugs. 
This in turn may induce lipid mixing between the aggregates and liposomes, including 
transfer of the fluorescent pyrene-labeled lipid analog from PoxnoPC aggregates to the 
PC/PS LUVs, and because of higher affinities of the drugs to the latter, could lead to 
augmented quenching of PPDPC in these vesicles. 
 
 
Figure 5.5 (A) Binding of 
DOX (?), CPZ (?), and HPD 
? ) to PazePC as revealed 
by the decrease in the relative 
fluorescence intensity (RFI) 
of PPDPC as a function of 
[drug]. Subsequent 
detachment of the bound 
drugs by added (B) NaCl, (C) 
POPC/POPS = 8:2 LUVs, or 
(D) DNA, evident as reversal 
of fluorescence quenching 
(RFQ) compared to the initial 
value before addition of the 
indicated solute. Total lipid 
concentration in 20 mM 
Hepes, 0.1 mM EDTA, pH 
7.4 was 25 ?M. Temperature 
was maintained at 25 oC.   
 
 
 
 
 
 
 
 
Several of the putative mechanisms of action ascribed to the antitumor effects of DOX 
involve interactions with DNA (Gewirtz, 1999). It was therefore of interest to observe, in 
accordance with previous studies revealing a high affinity of DOX to polynucleotides 
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(Mustonen and Kinnunen, 1993), that while the binding of DOX to both oxPLs persisted 
in physiological saline, this drug was readily scavenged from oxPLs by DNA, in contrast 
to HPD and CPZ (Fig. 5.5, D and 5.6, D). Notably, if DNA was replaced by 
polyphosphate (average chain length of 62 residues) essentially no dissociation of DOX 
from PazePC was  observed  even  when the  sample  phosphate  concentration  was  10-fold  
higher than the highest concentration present in similar experiments using DNA 
(calculated from its backbone phosphates; data not shown). 
 
 
Figure 5.6 (A) Binding 
of DOX (?), CPZ (?), and 
HPD  (?)  to  PoxnoPC  as  
revealed by the decrease in 
the relative fluorescence 
intensity (RFI) of PPDPC as 
a function of [drug]. 
Subsequent detachment of 
the bound drugs by added 
(B)  NaCl,  (C) POPC/POPS 
=  8:2  LUVs,  or  (D) DNA, 
evident as reversal of 
fluorescence quenching 
(RFQ) compared to the 
initial value before addition 
of the indicated solute. The 
experimental conditions 
were as described in the 
legend for Fig. 5.5. 
 
 
 
 
 
 
 
 
 
A quantitative analysis of the affinities of the drugs for the two oxPLs and lysoPC was 
carried out by determining their respective molar lipid/water partition coefficients, Kp 
(Table 5.2). Notably, the coefficient for partitioning of CPZ to PazePC was too high to be 
reliably determined by the method employed, and accordingly, only a rough estimate of > 
1 ? 108 could be obtained, indicating at least one order of magnitude higher affinity than 
measured between this drug and LUVs composed of the acidic phospholipid POPS, 2.2 ? 
107 (Parry et al., 2007). However, a stringent comparison of these two Kp values has to be 
made with caution since they were determined for two structurally different membrane 
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systems. Yet, these data together with the estimated three orders of magnitude higher Kp of 
CPZ  to  PazePC  compared  to  lysoPC  do  reveal  that  the  affinity  of  CPZ  to  this  lipid  is  
indeed very high. For PoxnoPC the Kp for HPD could not be determined since the addition 
of unlabeled PoxnoPC aggregates into a solution of PPDPC-labeled lipid with bound HPD 
increased the fluorescence intensity above the level recorded in the absence of the drug. 
The reason behind this behavior may lie in the lyotropic effect induced by an increase in 
PoxnoPC concentration together with the presence of HPD, whereupon the environment 
of PPDPC pyrenes residing in the aggregates becomes more hydrophobic leading to an 
increase of their fluorescence quantum yield. For lysoPC the partition coefficients 
obtained for CPZ and DOX were 2-3 times lower compared to PoxnoPC, and only a minor 
difference in the Kp of HPD between lysoPC and PazePC was evident. 
Table 5.2 The Kp between the aqueous phase and the lipid phase composed by PazePC, 
PoxnoPC, or lysoPC for the three drugs used in the study.  
Drug PazePC PoxnoPC lysoPC 
CPZ > 1 ? 108 1.70 ? 106 7.45 ? 105 
DOX 1.18 ? 106 1.92 ? 106 5.95 ? 105 
HPD 4.29 ? 105 ? 3.50 ? 105 
The values were obtained by assessing the drug-induced quenching of pyrene-labeled phospholipid 
analog (see Materials and Methods) 
5.2.2 Molecular interactions between oxPLs and cyt c  
To study if the functional groups of the two oxPLs are exposed to the aqueous phase and 
available for interactions with peripheral membrane proteins cyt c was utilized as a  
  
Figure 5.7 Binding of cyt c to PazePC and 
PoxnoPC as revealed by the decrease in the relative 
fluorescence intensity (RFI) of PPDPC as a function 
of [cyt c]. Total lipid concentration in 20 mM 
Hepes, 0.1 mM EDTA, pH 7.4 (solid symbols) or 20 
mM MES, 0.1 mM EDTA, pH 5.0 (open symbols) 
was 25 ?M. Temperature was maintained at 25 oC. 
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resonance energy transfer pair for PPDPC (XPPDPC = 0.01) incorporated into aggregates of 
the oxidatively modified phospholipids. At pH 7.4, cyt c bound avidly to PazePC, 
evidenced by an increase in efficiency of the resonance energy transfer leading to 
diminished pyrene fluorescence intensity (Fig. 5.7). The extent of quenching of pyrene 
emission is similar to that reported upon binding of cyt c to large unilamellar vesicles 
composed of the acidig phospholipid POPG (Tuominen et al., 2001) or cardiolipin 
(Mustonen et al., 1987) at pH 7.0, with [cyt c] = 0.6 ?M causing a ~ 70% decrease in 
fluorescence intensity. Upon lowering the bulk pH to 5.0, and thus increasing the extent of 
protonation of the carboxylic acid moiety of PazePC, the binding of cyt c was diminished 
to the low level observed for LUVs composed of eggPC (Mustonen et al., 1987). 
 
 
 
 
Figure 5.8 (A) Binding of cyt c to PazePC titrated up to [cyt c] ? 1 ?M, and corresponding to an 
overall protein/lipid ratio of ? 1:25. Subsequent detachment of the bound protein by added NaCl 
(B), ATP (C), and CaCl2 (D), evident as reversal of fluorescence quenching (RFQ) compared to 
the initial value prior to addition of the indicated solute. Total lipid concentration in 20 mM Hepes, 
0.1 mM EDTA, pH 7.4 was 25 ?M. In experiments involving CaCl2 the medium was 20 mM 
Hepes, pH 7.4. Temperature was maintained at 25 oC. 
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In order to elucidate further the molecular-level mechanism underlying the association 
between cyt c and PazePC, the ability of NaCl and ATP to dissociate the bound protein 
was studied. Increasing [NaCl] readily detached cyt c from PazePC, leading to a nearly 
complete recovery of the initial fluorescence intensity, with [NaCl] ? 15 mM needed for 
half-maximal reversal of fluorescence quenching (Fig. 5.8, B). This behavior is in contrast 
to  what  has  been  observed  for  neat  POPG  LUVs  in  pH  7.0,  from  which  an  increase  in  
ionic strength is able to dissociate the C-site bound cyt c only if this leads to sufficient 
decrease in pKa of the PG headgroup, causing its deprotonation (Träuble, 1976). Instead, 
the salt-induced dissociation of cyt c from PazePC resembles the behavior of POPC/POPG 
= 7:3 LUVs at pH 7.0, when cyt c is membrane-bound due to electrostatic interactions via 
its  A-site (Tuominen et  al.,  2001).  In keeping with the association of cyt c with PazePC 
involving the A-site, ATP in low millimolar range could dissociate the protein (Fig. 5.8, 
C), most likely due to a competition between the nucleotide and the deprotonated carboxyl 
moiety of the lipid for the same cationic site in cyt c. 
In the light of the above, it was of interest to study whether the exposure of the 
carboxyl function of PazePC to the aqueous phase would make it available for association 
with ions, such as Ca2+.  Accordingly,  because  of  the  high  affinity  of  Ca2+ for free fatty 
acids (Mironova et al., 2001) this should be reflected in the binding of cyt c to this lipid. 
To  this  end,  [CaCl2] ? 0.3 mM was needed for half-maximal dissociation of the bound 
protein, in keeping with the expected considerable affinity of this lipid for Ca2+ (Fig. 5.8, 
D).  It  has  been  reported  previously  that  another  divalent  cation,  Mg2+, dissociates cyt c 
from membranes composed of eggPC/cardiolipin LUVs with XCL =  0.1  (Rytömaa et  al.,  
1992), again in keeping with the involvement of the A-site. 
The primary aldehyde group of PoxnoPC could, in theory, react with proteins by 
forming Schiff’s adducts in a fashion reported for two in vivo aldehydic products of lipid 
peroxidation, malondialdehyde and 4-hydroxynonenal. In this process, a primary amino 
group of a protein, acting as a nucleophile, attacks the aldehyde group. However, only 
weak binding of cyt c to PoxnoPC was observed at either pH 7.4 or 5.0, indicating the lack 
of efficient covalent bond formation between this protein and PoxnoPC (Fig. 5.7).  
5.3 Impact of oxPLs on the association of antimicrobial peptides 
with model membranes 
5.3.1 Penetration of peptides into phospholipid monolayers 
In order to pursue the interactions of antimicrobial peptides (AMPs) with membranes 
containing oxidized phospholipids, the penetration of temporins B and L, indolicidin, and 
LL-37(F27W) into lipid monolayers was measured using a Langmuir balance. More 
specifically, the insertion of these AMPs into monolayers with different initial surface 
pressures ?0 was observed by recording the increase in the surface pressure ?? following 
the injection of the peptides into the aqueous subphase. In a low ionic strength subphase 
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both temporins B and L were highly membrane active, producing significant increment in 
surface pressure for all four monolayer compositions studied. (Fig. 5.9, A and B, Table 
5.3). Also indolicidin intercalated into the monolayers, albeit slightly less effectively, 
whereas LL-37(F27W) displayed membrane activity comparable to the temporins (Fig. 
5.9, Table 5.3). As expected from their positive net charges (+2, +3, +4, and +6 for 
temporin B, temporin L, indolicidin, and LL-37(F27W), respectively) all four peptides 
used in the present study interact preferably with monolayers containing acidic 
phospholipids. In keeping with the above, highest values of ?c were  recorded  for  films  
containing DMPG. Surprisingly, while PazePC bears an ionizable carboxyl function in its 
sn-2 acyl chain with a net negative charge, only indolicidin displayed augmented 
penetration into monolayers containing this oxidatively modified phospholipid (XPazePC = 
0.2) below surface pressure of ~ 35 mN/m. 
 
 
Figure 5.9 Penetration of anti- 
microbial peptides into lipid 
monolayers residing on low ionic 
strength buffer (20 mM Hepes, 0.1 
mM EDTA, pH 7.0), illustrated as 
increment in surface pressure (??) 
following the addition of 0.3 ?M 
temporin  B  (A),  temporin  L  (B), 
indolicidin (C), or LL-37(F27W) 
(D) into the subphase as a function 
of the initial surface pressure ?0. 
Monolayer compositions were 
DMPC  (?),  DMPC:DMPG  =  8:2  
??), DMPC:PoxnoPC = 8:2 (?), 
and DMPC:PazePC = 8:2 (?). 
 
 
 
 
 
 
 
 
 
Somewhat unexpectedly, the intercalation of all peptides into monolayers containing 
the aldehyde group bearing PoxnoPC was considerably enhanced over neat DMPC, this 
oxidatively modified phospholipid being almost as effective as DMPG in promoting 
peptide  penetration.  With  DMPG  and  PoxnoPC  (XPoxnoPC =  0.2)  the  values  of  ?c for 
temporin B increased from approximately 38 mN/m measured for neat DMPC up to ~ 48 
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mN/m and ~ 46 mN/m, respectively (Table 5.3). For temporin L there was less variation in 
?c between  different  monolayer  compositions,  with  DMPG  (XDMPG = 0.2) yielding the 
highest value of ~ 52 mN/m. In the case of indolicidin and LL-37(F27W), incorporation of 
DMPG into the monolayer resulted in clearly higher values for ?c (~ 60 and ~ 50 mN/m, 
respectively) compared to other lipid compositions. Notably, for all four peptides both 
DMPG and PoxnoPC enhanced considerably the intercalation at low surface pressures as 
evidenced by values of ?? at ?0 = 10 mN/m (Table 5.3). 
The above experiments were conducted in a low ionic strength medium. Accordingly, 
it was of interest to study the monolayer penetration using a subphase with physiological 
saline. Intriguingly, the two temporins and indolicidin intercalated into PoxnoPC 
containing  monolayers  as  efficiently  as  from  a  low  ionic  strength  subphase,  and  only  a  
minor decrement in ?c was noted for LL-37(F27W). Instead, as expected, their penetration 
into DMPG containing monolayers decreased due to screening of the electrostatic 
interactions by salt (Fig. 5.10). More specifically, in 150 mM NaCl temporin B inserted 
into neat DMPC monolayers up to ?0? ? 36  mM/m,  while  its  penetration  was  lightly  
augmented by both PazePC and DMPG (X = 0.2) with the value for ?c increasing up to ~ 
38 and ~ 40 mN/m, respectively. Notably, the intercalation of temporin B into monolayer 
containing PoxnoPC was enhanced with ?c increasing up to ~ 51 mN/m, thus exceeding 
the value measured in a low ionic strength medium (~ 46 mN/m, Table 5.3). 
Table 5.3 Monolayer critical packing pressures (?c) and estimated increase of surface pressure 
from initial value of 10 mN/m following peptide addition (??max)  for  temporins B 
and L, indolicidin, and LL-37(F27W).  
Lipid composition ?c (mN/m) ??max (at 10 mN/m) 
  No salt 150 mM NaCl No salt 150 mM NaCl 
Temporin B DMPC 37.7 36.3 16.1 17.7 
 XDMPG = 0.2 48.0 40.5 21.0 18.1 
 XPoxnoPC = 0.2 45.8 50.6 20.0 20.4 
 XPazePC = 0.2 37.7 38.5 18.5 17.9 
Temporin L DMPC 47.1 45.2 15.8 15.9 
 XDMPG = 0.2 51.9 45.9 18.9 18.9 
 XPoxnoPC = 0.2 46.7 49.2 19.9 20.6 
 XPazePC = 0.2 45.1 44.2 16.3 17.5 
Indolicidin DMPC 47.2 32.3 5.2 12.3 
 XDMPG = 0.2 60.1 49.2 11.7 5.8 
 XPoxnoPC = 0.2 47.0 44.1 12.9 12.2 
 XPazePC = 0.2 40.9 42.4 11.7 8.0 
LL-37(F27W) DMPC 38.8 39.0 18.5 21.7 
 XDMPG = 0.2 50.0 45.6 25.5 23.6 
 XPoxnoPC = 0.2 42.2 39.7 24.0 26.2 
 XPazePC = 0.2 41.5 36.9 21.4 23.6 
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In contrast to temporin B, with 150 mM NaCl in the subphase the presence of PazePC 
or DMPG (X = 0.2) in the monolayers enhanced the penetration of temporin L only at low 
surface pressures (~ 10-15 mN/m), while the ?c values for these monolayers remained 
nearly identical (~ 45 mN/m). As for temporin B, PoxnoPC promoted the monolayer 
penetration of temporin L yielding ?c?? 49 mN/m. In physiological [NaCl] the membrane 
intercalation of indolicidin into neat DMPC monolayers was considerably reduced at high 
packing densities, with ?c decreasing from 47 to 32 mN/m. However, concomitantly the 
penetration at lower surface pressures was promoted, exceeding that observed in the 
presence of DMPG. Also for monolayers containing PazePC the magnitude of indolicidin 
penetration was reduced, albeit less than for DMPG, whereas similarly to the temporins, 
the most effective intercalation of this peptide was found into monolayers containing 
PoxnoPC. With the exception of neat DMPC, the introduction of 150 mM NaCl into the 
subphase led to diminished intercalation of LL-37(F27W) into phospholipid monolayers. 
Again, highest reduction in ?c was observed for monolayers containing DMPG (XDMPG = 
0.2). The penetration of LL-37(F27W) into PoxnoPC containing monolayers was slightly 
attenuated  in  the  presence  of  physiological  saline.  However,  as  seen  for  indolicidin,  the  
penetration at lower surface pressures was promoted exceeding that observed for DMPG. 
 
 
Figure 5.10 Penetration of anti- 
microbial peptides into lipid 
monolayers residing on buffer 
with 150 mM NaCl, illustrated as 
increment in surface pressure (??) 
following the addition of 0.3 ?M 
temporin  B  (A),  temporin  L  (B), 
indolicidin (C), or LL-37(F27W) 
(D) into the subphase as a function 
of the initial surface pressure ?0. 
Monolayer compositions were 
DMPC  (?),  DMPC:DMPG  =  8:2  
??), DMPC:PoxnoPC = 8:2 (?), 
and DMPC:PazePC = 8:2 (?).
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In order to elucidate the potential role of the aldehyde moiety of PoxnoPC in the 
increased monolayer penetration of the AMPs, 1 mM methoxyamine was included in the 
subphase (with 150 mM NaCl) as an aldehyde scavenger prior to the injection of temporin 
L. The latter was chosen as it is the most surface active of the four peptides studied. 
Accordingly, an inhibitory effect arising from the masking of the aldehyde moiety of 
PoxnoPC should for this peptide be particularly discernible. Importantly, the intercalation 
of temporin L into monolayers containing DMPG was unaffected by methoxyamine 
(III:Fig. 5). In contrast, for PoxnoPC containing monolayers markedly decreased 
intercalation of temporin L was observed. Similar results were obtained in low ionic 
strength medium (data not shown). Hence, a specific interaction such as efficient hydrogen 
bonding or Schiff base adduct formation between the primary amino groups of the AMPs 
and the aldehyde function is likely to be involved in the PoxnoPC – peptide interaction. 
5.3.2 Peptide Trp fluorescence 
To obtain further insight into the interaction of AMPs with the two oxPLs, the intrinsic 
tryptophan fluorescence of temporin L, indolicidin, and LL-37(F27W) was utilized to 
probe their molecular surroundings upon binding to LUVs. To allow for the comparison 
with the monolayer data, the same phospholipids were used and temperature maintained at 
25 oC, where the LUVs are above their main transition and thus in liquid disordered 
(“fluid”) state. Emission spectra of these three peptides were recorded in the absence as 
well as in the presence of LUVs of different lipid compositions (viz. DMPC as such and 
with DMPG, PoxnoPC, and PazePC, each at X = 0.2) both in low ionic strength buffer as 
well as in the presence of 150 mM NaCl.  
In aqueous solution the Trp residue(s) of the peptides emit with a maximum at ~ 352-
354 nm, indicating that they reside in a polar environment. A relocation of Trp residues 
into a less polar environment such as the hydrocarbon phase of lipid membranes causes 
changes in Trp fluorescence quantum yield and emission maximum (Cowgill, 1967). 
Representative fluorescence spectra of temporin L (III:Fig. 3) in low ionic strength reveal, 
upon the addition of DMPC LUVs, a blue shift in ?max by 14 nm (Table 5.4), together with 
an increase in the emission intensity, both indicative of association of the peptide with the 
vesicles. More pronounced increase in both the intensity and blue shift (24 nm) were 
observed following the addition of vesicles containing DMPG, in keeping with previous 
studies (Zhao and Kinnunen, 2002). For LUVs containing PazePC (XPazePC = 0.2), the blue 
shift was smaller (15 nm) compared to XDMPG = 0.2 while the emission intensity was 
attenuated compared to neat DMPC vesicles. Similar blue shift by 18 nm together with 
augmented  decrement  in  Trp  emission  was  observed  also  for  PoxnoPC  (XPoxnoPC = 0.2, 
III:Fig. 3, Table 5.4). In physiological saline the emission intensity after the addition of 
DMPG containing vesicles decreased, in contrast to a slight increase for PazePC and 
DMPC.  Interestingly,  the  impact  of  PoxnoPC  was  identical  irrespective  of  the  ionic  
strength of the solution (III:Fig. 3, Table 5.4). 
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The blue shift of emission maximum of indolicidin was almost completely insensitive 
to vesicle lipid composition and ionic strength (III:Fig. 3, Table 5.4). However, 
considerable variation in emission intensity was observed. Both with and without 150 mM 
NaCl the addition of DMPG containing vesicles resulted in the highest Trp emission. The 
fluorescence intensity in the presence of vesicles containing XPazePC = 0.2 equaled that 
measured for neat DMPC LUVs under low ionic strength. In the presence of LUVs with 
XPoxnoPC = 0.2, as well as XPazePC = 0.2 and in physiological saline, Trp emission intensity 
of indolicidin was lower than for DMPC vesicles (Table 5.4). With the exception of a 
marked decrease with PoxnoPC containing vesicles, essentially no changes in 
fluorescence quantum yield were observed following the binding of LL-37(F27W) to 
liposomes. As for indolicidin, the blue shift of emission maximum of this peptide did not 
vary with ionic strength or liposome composition. 
Table 5.4 Maximum emission wavelengths of Trp fluorescence of temporin L, indolicidin, 
and LL-37(F27W) (?max)  and  its  blueshift  compared  to  the  value  recorded  in  
aqueous buffer (??max) induced by liposome sod indicated compositions. 
 LUV 
composition 
?max (nm) ??max (nm) RFI 
  No 
salt 
150 mM 
NaCl 
No 
salt 
150 mM 
NaCl 
No 
salt 
150 mM 
NaCl 
Temporin L ? 352 352 ? ? 166 161 
 DMPC 338 337 14 15 214 222 
 XDMPG = 0.2 328 332 24 20 263 245 
 XPoxnoPC = 0.2 334 335 18 17 99 91 
 XPazePC = 0.2 337 338 15 14 155 168 
Indolicidin ? 352 352 ? ? 475 473 
 DMPC 341 341 11 11 802 922 
 XDMPG = 0.2 340 340 12 12 960 953 
 XPoxnoPC = 0.2 342 342 10 10 456 420 
 XPazePC = 0.2 341 342 11 10 791 607 
LL-37(F27W) ? 352 352 ? ? 197 210 
 DMPC 337 336 15 16 201 189 
 XDMPG = 0.2 337 336 15 16 201 197 
 XPoxnoPC = 0.2 338 337 14 15 142 118 
 XPazePC = 0.2 337 336 15 16 211 192 
 
 
In order to verify the insertion of the three peptides into the hydrophobic region of the 
bilayers indicated by the above changes in Trp emission spectra, collisional quenching by 
acrylamide was utilized. Importantly, this quencher is devoid of electrostatic interactions 
with the headgroups of negatively charged lipids and because of being highly water 
soluble it provides a measure of the solvent exposure of the Trp residues of the peptides. 
Stern-Volmer plots of Trp fluorescence quenching by acrylamide constructed from the 
RESULTS 
 
 
 
 
57
data recorded in the absence and presence of vesicles of indicated compositions reveal in 
all cases a concentration-dependent decrease in fluorescence (III:Fig. 4), However, 
decrease in fluorescence is significantly reduced in the presence of liposomes, 
demonstrating reduced accessibility of Trp to the quencher, and thus insertion of the 
peptides into the vesicles. 
At low ionic strength the values of KSV for  temporin  L  show  a  major  decrease  with  
neat  DMPC  vesicles  while  slightly  better  access  of  acrylamide  to  Trp  is  seen  for  LUVs  
with XPazePC = 0.2. Instead, compared to DMPC the values for KSV were further decreased 
in the presence of DMPG and PoxnoPC containing LUVs. Similar changes in KSV values 
were evident also for indolicidin and LL-37(F27W) following incubation with liposomes, 
with the exception of the binding of the latter peptide to PazePC containing vesicles 
resulting in less efficient quenching compared to neat DMPC LUVs (Table 5.5). At 150 
mM NaCl a general increase in quenching efficiency of Trp fluorescence was observed for 
all three peptides indicating decreased membrane partitioning and/or relocation of the Trp 
residue(s) closer to the interface following increase in ionic strength. Yet, the lowest KSV 
values were again measured for liposomes containing DMPG or PoxnoPC (Table 5.5). 
Table 5.5 The Stern-Volmer quenching constants KSV (M-1) of acrylamide for temporin L, 
indolicidin, and LL-37(F27W) in the absence and the presence of vesicles of the 
indicated compositions. 
  KSV (M-1) 
 LUV composition No salt 150 mM NaCl 
Temporin L ? 12.93 ± 0.16 12.90 ± 0.11 
 DMPC 1.48 ± 0.08 1.65 ± 0.07 
 XDMPG = 0.2 1.01 ± 0.06 1.22 ± 0.05 
 XPoxnoPC = 0.2 0.88 ± 0.14 1.22 ± 0.11 
 XPazePC = 0.2 2.18 ± 0.09 2.34 ± 0.05 
Indolicidin ? 9.31 ± 0.15 9.29 ± 0.10 
 DMPC 2.37 ± 0.04 2.30 ± 0.06 
 XDMPG = 0.2 1.25 ± 0.01 1.37 ± 0.02 
 XPoxnoPC = 0.2 1.91 ± 0.03 2.04 ± 0.03 
 XPazePC = 0.2 2.62 ± 0.03 2.63 ± 0.02 
LL-37(F27W) ? 11.87 ± 0.23 11.45 ± 0.14 
 DMPC 2.40 ± 0.07 2.59 ± 0.09 
 XDMPG = 0.2 1.31 ± 0.07 1.64 ± 0.05 
 XPoxnoPC = 0.2 1.58 ± 0.07 1.82 ± 0.07 
 XPazePC = 0.2 1.83 ± 0.06 2.24 ± 0.07 
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6 Discussion 
The concepts interconnecting the original publications comprising the present thesis are 
the molecular properties of oxidatively modified phospholipids and the structural and 
functional modifications their generation imposes on lipid bilayers with special emphasis 
on the modulation of membrane partitioning of diverse molecules. Publication I describes 
an investigation aimed to elucidate the surface chemical properties of two distinct oxidized 
phospholipids as well as their structural dynamics in a matrix composed of saturated 
phospholipids. The accompanying publications (II-IV) address the putative capacity of the 
same oxidatively modified phospholipids to bind proteins, peptides, and small amphiphilic 
molecules via hydrophobic, electrostatic, and covalent interactions mediated by the 
functional groups located at their truncated sn-2 chains exposed on the membrane surface. 
6.1 The impact of oxidative modifications on the structural 
dynamics of phospholipid membranes 
Lipid oxidation has been documented to impair several membrane associated cellular 
processes including transmembrane ion transport (Stark, 2005) and hydrolytic activity of 
phospholipase A2 (van Kuijk et al., 1988; McLean et al., 1993). As these effects may 
result from the modulation of membrane physical properties, it was of interest to assess 
and compare the surface properties of two oxidatively modified phospholipids PazePC and 
PoxnoPC, as reflected in their impact on mixed monolayers with unoxidized 
phospholipids. These two lipids were chosen for this study in order to evaluate 
unambiguously the contribution of the aldehyde and carboxyl functions to their properties. 
Further, both PazePC and PoxnoPC are produced in vivo and have been isolated from 
various biological sources including oxidized LDL (Davies et al., 2001) and ozone-treated 
lung surfactant extract (Uhlson et al., 2002), respectively. 
6.1.1 Extended lipid conformation involving the oxidatively modified sn-2 
chains 
When mixed with DPPC, both oxPLs induced considerable expansion of binary 
monolayers at surfaces pressures below the high pressure transition at ?s (Fig. 5.2, A and 
B). This observation can be readily rationalized in terms of a model where the hydrophilic 
group bearing sn-2 acyl chains of PazePC and PoxnoPC would reverse their direction so 
as to accommodate the polar moieties into the vicinity of the lipid headgroups in the air-
water interface and thus minimizing the free energy penalty caused by burying the polar 
groups within the hydrophobic (low dielectricity) membrane core (Fig. 6.1). The above is 
in keeping with previous experimental (van Kuijk et al., 1988) and recent computational 
(Wong-ekkabut et al., 2007) studies revealing that oxidatively modified fatty acyl chains 
of phospholipids are likely to locate closer to the interface than the corresponding 
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unoxidized chains and thereby to induce lateral expansion of the membrane. Chain 
reversal is well established also for fluorescent phospholipid analogs bearing aromatic 
moieties in the sn-2 chain (Alakoskela and Kinnunen, 2001). The observed film expansion 
was more pronounced for PazePC, most likely reflecting the Coulombic repulsion 
between the negative charges of lipid headgroup phosphates and the deprotonated 
carboxyl moieties together with possible difference in the size of the hydration shell of the 
aldehyde and carboxyl groups of PoxnoPC and PazePC, respectively.  
 
 
 
Figure 6.1 A schematic illustration of the possible arrangements of the sn-2 acyl chains of 
PazePC and PoxnoPC in DPPC during monolayer compression. See text for details. 
As both aldehyde and carboxyl groups have considerable electric dipole moments their 
accumulation to the interfacial region can also readily explain the progressive decrease of 
the monolayer surface potential with increasing XoxPL (Fig. 5.3, C and D). In addition, 
steric constraints following from interfacial crowding may lead to reorientation of the 
intramolecular electric dipoles of DPPC, in particular the P–-N+ -dipoles of the 
phosphocholine headgroups leading to further modulation of the interfacial potential. For 
PazePC, the above could result also from electrostatic interactions analogously to the 
reorientation of the headgroup dipoles observed to accompany the inclusion of cationic 
gemini surfactants into POPC monolayers (Säily et al., 2001).  
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Importantly, reversal of the sn-2 chains alone is not sufficient to explain the presence 
of the shoulder at 42 mN/m (Fig. 5.2, A and B)  and  the  decrease  of  the  area  at  collapse  
from 40 to 25 Å2/molecule with XoxPL = 0.4. On the contrary, the A/molecule at collapse 
should increase because of the presence of the bulky polar groups at the air-water 
interface. This contradiction suggests that in addition to the above process, the modified 
sn-2 chains subsequently adopt the so-called extended lipid conformation (Kinnunen, 
1992), whereupon they would protrude out of the monolayer plane (Fig. 6.1, B) and 
ultimately dissolve into the aqueous subphase as the A/molecule is reduced further (Fig. 
6.1, C). The condensing effect by oxPLs on DPPC monolayers at ? > ?s appears therefore 
to be apparent only and is caused by the loss of the oxidatively modified lipids into the 
subphase. To this end, extrapolation of the ? versus XoxPL data at ? = 50 mN/m (Fig. 5.2, C 
and D) to XoxPL = 1.0 approaches zero for both PazePC and PoxnoPC, in keeping with the 
loss  of  the  oxidized  lipids  from  the  monolayer.  Finally,  the  fact  that  neat  PoxnoPC  and  
PazePC films collapse at pressures slightly lower than the values for ?s for the mixed films 
suggests that the regions where solubilization occurs are either binary mixtures of the 
oxPLs and DPPC, enriched in the former, or that they are very small so that the 
surrounding matrix may retain small amounts of the departing oxPLs in the film. Due to 
their surfactant-like characteristics the oxPL molecules forced out from the membrane will 
initially dissolve as free monomers, although a population of soluble aggregates is likely 
to form if their concentration in the aqueous medium reaches a sufficiently high level.  
Adaptation of the extended conformation provides a rational explanation also for the 
changes in the surface potential preceding the loss of the oxPLs from the monolayer. 
Accordingly, the shoulder observed in the ??-A data for oxPL containing monolayers 
(Fig. 5.3, A and B) is likely to result from the modulation of the surface potential by the 
extension of the polar groups of the sn-2 chains into the aqueous phase and the 
concomitant reorientation of the headgroup dipoles during film compression. At higher 
packing densities the component of the monolayer dipole moment vector perpendicular to 
the monolayer plane (??) goes through a sharp local maximum at XoxPL =  0.1,  its  value  
subsequently decreasing back to the level of pure DPPC at XoxPL = 0.2 (Fig. 5.3, G and H). 
Thus, it seems plausible that the maximal reorientation of molecular electric dipoles 
occurs between these XoxPL values. Additional evidence in keeping with the scheme 
described in figure 6.1 arises from simple analytical consideration based on the surface 
potential data, as follows: the value for A/molecule ? 34 Å2 for  PoxnoPC/DPPC  with  
XPoxnoPC = 0.4 at the film collapse corresponds to surface potential of ~ 500 mV (Fig. 5.3, 
A). Correcting this for XDPPC we obtain 34 Å2/0.6 ? 56.7 Å2, which agrees well with the 
A/molecule = 56 Å2 for pure DPPC at the same value of surface potential. Accordingly, 
the surface potential data supports the conclusion that during compression the structural 
rearrangements of the binary monolayers constitute a biphasic process, in which the oxPLs 
in the DPPC matrix first adopt the extended conformation and subsequently dissolve into 
the subphase upon further increase in ?. Interestingly, the ability of monolayers containing 
oxidized phospholipid species to accumulate the 42-residue form of amyloid ?-protein 
(A?42) is attenuated at high surface pressures (? > 35 mN/m), presumably due to loss of 
interactions between the protein and functional groups of the oxPLs (Koppaka and 
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Axelsen, 2000). Based on findings introduced here, it seems likely that this reflects the 
loss of oxPLs from the monolayer diminishing the association of A?42 with the lipid film.    
The effects imposed by the two oxPLs on monolayer lateral organization were 
qualitatively rather similar, as judged from the fluorescence microscopy images (Fig. 5.4). 
Yet, there were subtle differences including the diminished number and larger size of the 
nonfluorescent solid domains evident in PazePC/DPPC monolayers. In contrast, PoxnoPC 
molecules seem to be more equally distributed in the monolayer matrix leading to smaller 
and more numerous DPPC domains and increased length of the phase boundary separating 
the DPPC enriched solid domains and the LE phase concentrated in oxPLs. This suggests 
the line tension acting between the two coexisting phases to be lower in binary mixtures 
containing PoxnoPC, likely reflecting the more complete exclusion of PazePC molecules 
bearing  a  bulky  –COOH  moiety  from  the  solid  phase.  At  XoxPL >  0.1  both  PazePC  and  
PoxnoPC induce a considerable increase in the fraction of the lipid film in the LE phase at 
a given surface pressure (Fig. 5.4). The increase in fluidity can be attributed to the reverse 
orientation of the oxidatively modified chains, since this creates voids in the lipid matrix 
of the monolayer and concomitantly allows for the augmented motional freedom of the sn-
1  chains  of  the  oxPLs  as  well  as  the  chains  of  their  neighbouring  DPPC  molecules.  In  
contrast to the above, at XoxPL = 0.1 a decrement in the fraction of the LE phase is seen for 
both  PazePC  and  PoxnoPC  containing  monolayers.  Since  at  the  same  mole  fraction  the  
maximum in ?? is observed, it is tempting to speculate that this alteration in the monolayer 
phase state is connected to oxPL induced orientation of the phospholipid headgroups.  
Taken together, the packing density dependent changes in the orientation of the 
oxidatively modified chains readily imply phospholipids such as PoxoPC and PazePC to 
have profound effects on several key physical properties of membranes, including acyl 
chain order, the lateral pressure profile as well the dielectricity gradient (e.g. the polarity 
profile) and membrane surface electrostatics. As a consequence, oxidation of membrane 
lipids should have considerable impact on the conformation, activity, and attachment of 
membrane proteins. In order to assess whether the latter could be influenced by the 
looping of the oxidized chains to the interface and/or their extension into the aqueous 
medium, the association of a water-soluble peripheral membrane protein cyt c with both 
PazePC and PoxnoPC was estimated semiquantitatively using fluorescence energy transfer 
(Fig. 5.8). Whereas only neglible binding of cyt c to PoxnoPC was observed, PazePC 
bound this protein avidly. The association was readily reversed by increase in ionic 
strength as well as ATP and Ca2+-ions thereby indicating it to be mediated via 
electrostatics between the deprotonated carboxyl moiety at the lipid-water interface and 
cationic residues at the protein surface (A-site binding) (Fig. 6.2). No indication of a 
hydrophobic component in the binding mechanism was evident, thus ruling out the 
possibility of C-site binding involving insertion of sn-2 chains into a hydrophobic cavity 
in cyt c, as described for phospholipids with protonated phosphoglycerol headgroups 
(Tuominen et al., 2002). Notably, previous circular dichroism (Pinheiro et al., 1997) and 
NMR (Pinheiro et al., 2000) studies have revealed that electrostatic binding to 
phospholipids with negatively charged headgroups induces cyt c to adopt a non-native 
conformation leading to structural destabilization of the protein. Although such a 
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possibility was not evaluated in the present study, it is plausible that a similar 
conformational change could take place upon interaction of cyt c with PazePC.  
Very recently, a molecular level model depicting the organizational structure of 
oxidized lipid membranes was postulated to describe their specific recognition by 
macrophages (Greenberg et al., 2008). More specifically, the model involves protrusion of 
the oxidatively modified acyl chains to the aqueous phase analogously to the scheme 
introduced in figures 6.1 and 6.2. In this conformation the polar functional groups of the 
chains are made available for specific recognition by scavenger receptors residing on the 
surface of macrophages, thus implicating them as molecular pattern ligands. As adaption 
of the extended lipid conformation is a prerequisite for this role, molecular reorientation of 
oxidized phospholipids as described in the present study is suggested to play a prominent 
role in innate immune functions in vivo (Hazen, 2008).  
 
 
Figure 6.2 A schematic illustration of the putative model of association between cytochrome c 
and PazePC 
6.2 Molecular interactions of oxidized phospholipids with 
amphipathic drugs and peptides 
Adaption of the extended conformation renders the functional groups at the end of the sn-2 
acyl chains of PazePC and PoxnoPC available for interactions with the structures in the 
headgroup region of the matrix lipids as well as molecules dissolved in the surrounding 
aqueous media, as demonstrated above for the paradigm of peripheral membrane proteins, 
cyt c. Since proper membrane interactions are crucial for a wide variety of bioactive 
molecules, this issue was explored further using amphiphilic pharmaceuticals and 
antimicrobial peptides.  
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6.2.1 Oxidized phospholipids retain therapeutic agents through noncovalent 
interactions: possible pharmacological implications 
Quantitative assessment of the interactions of three currently widely used therapeutic 
agents, viz. the antipsychotics HPD and CPZ, and the antineoplastic anthracycline DOX 
(Fig. 6.3) with PazePC and PoxnoPC revealed that all three drugs bind the two oxPLs with 
high affinity, as judged from the high values of the molar lipid/water partition coefficients 
(Table 5.2). Monitoring the dissociation of the drug-oxPL complexes following increase in 
ionic strength or addition of liposomes containing anionic phospholipids revealed their 
formation to be driven by hydrophobic (PoxnoPC) or combination of hydrophobic and 
electrostatic interactions (PazePC). Notably, the above experiments were conducted using 
molecular aggregates spontaneously formed upon dispersion of the oxPLs into an aqueous 
medium above their respective CMCs. At present the exact structural characteristics of 
these aggregates remain unresolved. However, some insight into this issue was gained 
from fixed angle dynamic light scattering (DLS) experiments assessing the size 
distribution of mixed aggregates of oxPLs and lysoPC. The latter bears a close structural 
resemblance to PazePC and PoxnoPC due to the missing sn-2 acyl chain and is known to 
form spherical micelles in aqueous solutions. A diameter of ~ 6 nm was measured for neat 
lysoPC micelles in keeping with previous reports (Pasquali-Ronchetti et al., 1983). Mixed 
oxPL/lysoPC aggregates retained a comparable size up to XoxPL = 0.5, but a further 
increase in the content of either PazePC or PoxnoPC caused their diameter measured by 
DLS  to  drop  below  1  nm,  a  value  too  small  to  be  realistic  for  spherical  (micellar)  
aggregates (II:Fig. 7). It is thus plausible that the oxPLs in aqueous solutions form 
nonspherical aggregates and may induce a similar morphology in other membrane systems 
if present above a certain critical mole fraction. Importantly, however, these complications 
do not undermine the conclusions of this work, since effects arising from aggregate size 
and shape (e.g. variation in curvature) should influence the drug binding only in a 
quantitative manner, not affecting the specificity of the observed interactions between the 
drugs and the two oxPLs. 
In addition to their amphiphilic nature, the rationale behind the choice of the drugs 
used in the present investigation stems from the documented capability of these molecules 
to induce oxidative imbalance on the cellular level (Doroshow et al., 1980; Pillai et al., 
2007). Out of the three, HPD and CPZ are used in the treatment of schizophrenia due to 
their antipsychotic and anxiolytic properties. At present the molecular pathogenesis of 
schizophrenia and associated neurobiological abnormalities remain elusive, but along with 
hyperactivity of dopaminergic neurotransmission, the involvement of oxidative stress 
(Mahadik and Mukherjee, 1996), together with changes in membrane lipids (Fenton et al., 
2000) and elevated activity of phospholipase A2 (Gattaz et al., 1987) have been 
implicated. The observed pharmacodynamics of HPD and CPZ are generally attributed to 
the capability of these compounds to act as antagonist of various postsynaptic receptors 
including several subtypes of dopamine receptors. Yet, based on the fact that both 
neuroleptics readily partition into phospholipid membranes, it has been suggested that 
they exert the observed pharmacological effects in part by altering the function of these 
receptors as well as other proteins of postsynaptic membranes through modulation of the 
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lateral organization of their phospholipid matrix (Jutila et al., 2001). While at this stage it 
would certainly be premature to assign even a putative role to the interaction between the 
oxPLs and the two antipsychotic drugs in their mechanism(s) of action, these interactions 
could be relevant and could also be involved in their known side effects. More 
specifically, increased oxidative stress has been associated with the pathogenesis of 
tardive dyskinesia and other extrapyramidal side effects of the antipsychotic treatment of 
schizophrenia (Cadet and Lohr, 1989). Chronic exposure to HPD and CPZ has been 
shown to decrease the expression and activity of key antioxidant enzymes and to elevate 
the level of lipid peroxides in murine brain, the changes induced by HPD being more 
pronounced and appearing at an earlier stage (Pillai et al., 2007). In humans, the use of 
HPD to counter the clinical symptoms of schizophrenia is associated with more frequent 
and severe adverse motoric effects compared to CPZ (Leucht et al., 2008). In light of the 
present results, it could be speculated that the relative affinities of HPD and CPZ towards 
oxPLs generated during oxidative stress may explain at least in part the differences in the 
antioxidant status and the level of lipid peroxides measured after administration of the two 
neuroleptics, as well as their differing side effect profiles. Accordingly, avid binding of 
CPZ to phospholipid oxidation products may temporarily hamper the propagation of free 
radical chain reactions and thus inhibit the spreading of the oxidative membrane damage 
due to ROS following from diminished antioxidant enzyme activity associated with 
antipsychotic therapy. In addition, scavenging of oxPLs by CPZ may reduce their 
detrimental effects imposed on the functionality of membrane proteins. In keeping with 
the latter, the ligand affinities of postsynaptic 5-hydroxytryptamine and dopaminergic 
receptors associated with the extrapyramidal side effects are recognized to be modulated 
by oxidation of membrane lipids (Rego and Oliviera, 1995 and references therein).  
The formation of drug-oxPL complexes may relate also to the alterations in the activity 
of phospholipase A2 associated with the administration of neuroleptics. More specifically, 
the augmented serum activity of PLA2 in drug-free schizophrenic patients is reduced to the 
level observed for healthy controls following a three-week neuroleptic treatment (Gattaz et 
al., 1987). The molecular basis for the changes in the enzyme activity in the above 
scenario has yet to be delineated, but cytosolic PLA2 is known to be upregulated in 
oxidative stress (Chen et al., 1996) and to exhibit increased hydrolytic activity towards 
oxidized  phospholipids  (McLean  et  al.,  1993).  To  this  end,  altered  physical  state  of  the  
membrane substrate brought about by oxidative damage together with factors such as 
enhanced protein kinase C or MAP-kinase mediated phosphorylation and Ca2+ binding of 
membrane-bound PLA2 in the presence of oxPLs have been suggested to underlie the 
preferential hydrolysis of oxidatively modified membranes by this enzyme (Rashba-Step 
et al., 1997; Lupo et al., 2005). The decrement in PLA2 activity associated with 
administration of typical neuroleptics such as CPZ and HPD is unlikely to follow simply 
from reduced generation of oxPLs or synthesis of PLA2 since these drugs are known 
inducers of oxidative stress, as described above. A more plausible mechanism resting on 
the present results involves the complexation of amphiphilic neuroleptics with bioactive 
oxPLs so as to mask the functional groups of the latter, thereby reducing their 
physiological impact with respect to the modulation of membrane physical properties and 
lipid-protein interactions. This would account for the effect of neuroleptic agents on PLA2 
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activity in the presence of oxidative stress without any direct interaction between the drug 
and enzyme molecules or a significant change in the cellular redox status. Notably, as the 
hydrolysis of the modified sn-2 chains represents an important contributor to the repair of 
oxidative membrane damage (van Kuijk et al., 1988), a long-term reduction in PLA2 
activity in combination with unaltered rate of oxPL generation is likely to exacerbate 
oxidative cell damage and trigger progression of oxidative stress associated 
neuropathologies, including extrapyramidal disorders. 
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Figure 6.3 The chemical structures of chlorpromazine (CPZ), haloperidol (HPD), and 
doxorubicin (DOX). 
 
DOX is an intravenously administered anthracycline commonly used in the treatment 
of a wide range of cancers, although development of acute congestive heart failure with 
cumulative doses limits its clinical utility (Green et al., 1984). The molecular basis of the 
broad-spectrum antineoplastic activity of DOX is commonly attributed to its capability to 
interfere with the process of replication by intercalating into chromosomal DNA and 
concomitantly inhibiting the activity of topoisomerase II (Gewirtz, 1999). Yet, the 
mechanisms underlying the cytotoxic and antiproliferative effects of DOX are likely to be 
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more complex and involve several targets in addition to those localized inside the nucleus. 
Along these lines, DOX bound to polymer beads and solely contacting the outer surface of 
the plasma membrane of cultured cells has also been shown to be cytotoxic (Triton and 
Yee, 1982), thus revealing the entry of DOX into target cells not to represent an absolute 
prerequisite for the expression of its pharmacological activity. In addition, comparison of 
the effective DOX concentrations to which the cells were exposed led to the conclusion 
that polymer-bound DOX is approximately 100 to 1000 times more lethal compared to 
free DOX having unhampered access to intracellular targets. 
As for other quinone anthracyclines, oxidative stress evoked by DOX is well 
established both in vitro and in vivo. DOX may act as an electron acceptor in reactions 
catalyzed by intracellular or cell surface-bound oxoreductive enzymes (Keizer et al., 
1990), resulting in the formation of a semiquinone free radical which can subsequently 
autooxidize back to DOX with a simultaneous generation of various ROS. Alternatively, 
DOX-iron complex spontaneously produces hydroxyl radical from hydrogen peroxide via 
the Haber-Weiss reaction without enzymatic involvement (Doroshow, 1983). DOX 
residing in the immediate vicinity of cellular membranes is therefore capable of triggering 
oxidation of their molecular components, potentially affecting cell viability through 
disruption of membrane associated processes. Further, oxidation of membrane 
phospholipids produces various modified species which are recognized to directly induce 
apoptosis or mediate the intracellular transmission of proapoptotic signals culminating in 
cell death (see section 2.2.3). The role of lipid oxidation in the biological activity of DOX 
is also substantiated by findings demonstrating that dietary supplementation with a ?-3 
polyunsaturated fatty acid (DHA) increases the susceptibility of two human breast cancer 
cell lines to the cytotoxic effects of DOX (Mahéo et al., 2005). More specifically, 
chemosensitization of the cells to DOX was achieved through augmented incorporation of 
the highly oxidizible DHA into the phospholipid fraction of cellular membranes thus 
rendering it more prone to ROS mediated damage. This was observed to correlate with 
increase in levels of lipid oxidation products in the presence of DOX as well as enhanced 
cytotoxic efficacy of the drug. Importantly, chemosensitization was not associated with 
changes in the intracellular accumulation of DOX subsequent to DHA supplementation. 
Taken together, the above can be considered as strong evidence favoring the 
hypothesis that DOX elicits tissue damage via an intricate multifactorial mechanism 
involving interactions with the DNA double helix as well as promotion of cellular 
oxidative stress. While these individual processes are likely to act in parallel to induce 
impairment of cellular processes following exposure to DOX, their relative impact may 
vary from one cell type to another. Accordingly, tissues characterized by limited 
antioxidant defences, such as the heart, are more susceptible to the detrimental effects 
arising from oxidative stress brought about by DOX-induced ROS, whereas others more 
readily mitigate this oxidative challenge (Doroshow et al., 1980). The antimitotic activity 
of  DOX  may  thus  be  directly  related  to  its  toxic  side  effects  manifested  in  specific  
nontargeted tissues. In keeping with the prominent role of oxidative damage to the cellular 
membranes, prior administration of either the lipophilic antioxidant ?-tocopherol (Wahab 
et al., 2000) or the iron chelator dexrazoxane (Herman and Ferrans, 1998) reduces the 
acute  cardiotoxicity  of  DOX in  mice.  Accordingly,  the  observed  strong  affinity  of  DOX 
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towards oxPLs is therefore likely to perpetuate the local oxidative attack, as it would 
retain the drug molecules in the affected membrane and lead to effective oxidation of its 
molecular constituents following depletion of the pool of intrinsic ROS scavengers. 
Beyond the plasma membrane, the intracellular membranes of mitochondria and the 
endoplasmic reticulum of represent particularly vulnerable targets for the undesirable 
effects of DOX chemotherapy as they harbor oxoreductive NADH dehydrogenase and 
NADPH:cytochrome P-450 reductase enzymes, respectively, participating in the redox 
cycling of the DOX molecules. The role of the former enzyme is likely to be particularly 
prominent in cardiotoxicity of DOX due to the abundance of mitochondria in cardiocytes 
(Davies and Doroshow, 1986). It is tempting to speculate that the initial DOX catalyzed 
lipid oxidation leads to augmented partitioning of the drug to intracellular membranes due 
to efficient binding to oxPLs, as outlined above. This would consequently exacerbate 
membrane oxidative damage, thus resulting in a vicious cycle. As an outcome, 
interference of central membrane associated functions such as cellular energy production 
and maintenance of Ca2+ homeostasis is readily expected, along with increased generation 
of bioactive oxPLs capable of diffusing within or even escaping the affected membrane 
and subsequently triggering intracellular cascades resulting in cellular dysfunction or 
death. Although empirical evidence is lacking, it is reasonable to assume that both of the 
above mechanisms involving oxPLs could be relevant in relation to the cytotoxicity of 
extracellularly immobilized DOX, as well as free DOX retained in cellular membranes. 
To summarize, three cationic amphiphilic therapeutic agents were observed to express 
high affinity towards two biologically pertinent oxidatively modified phospholipids. It 
must be stressed that the pharmacological implications of the above, if any, remain 
unresolved. Yet, it is suggested that oxPLs may represent potential novel drug targets, as 
(i) they are generated in increased amounts in given tissues upon various pathological 
conditions, (ii) they often posses biological activity controlling cell behaviour, and (iii) 
their physicochemical properties differ significantly from those of their nonoxidized 
parent molecules, allowing for the design of specific high-affinity oxPL scavengers. 
Notably, an analogous concept was described recently for the specific sequestration of 
phosphatidic acid, a lipid second messenger involved in promotion of cell growth, by a 
small cationic ?-receptor agonist siramesine possessing documented but hitherto obscure 
anticancer properties (Parry et al., 2008). Lastly, efficient binding to oxPLs could have an 
undesirable impact on the ADME-characteristics (Absorption, Distribution, Metabolism, 
and Excretion) of various amphiphilic drugs, affecting in particular their distribution 
within the various cellular and tissue compartments.  
6.2.2 Membrane association of AMPs is promoted by PoxnoPC 
Antimicrobial peptides, also known as host defence peptides, are evolutionarily conserved 
effector molecules in the innate immune response of virtually all living matter. AMPs 
isolated from natural sources are typically small (10-50 residues, MW < 10 kDa), 
positively charged peptides encoded as larger inactive precursors and expressed either 
constitutively or inducibly (Hancock and Lehrer, 1998). They are potent, broad spectrum 
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antibiotics which demonstrate potential also as templates for prospective therapeutic tools 
in combating infections by microorganisms resistant to conventional antimicrobial agents 
(Jenssen et al., 2006). As a recurrent structural feature the polar residues of AMPs are 
segregated into separate patches flanked by hydrophobic regions, which provides the 
molecules their characteristic amphiphilic properties. This in conjunction with their 
cationic net charge allows for efficient interactions with bacterial membranes enriched in 
negatively charged phospholipid species and lipopolysaccarides. Accordingly, the central 
dogma of bacteriocidal action of AMPs involves their partitioning into the outer and 
cytoplasmic bacterial membranes facilitated by electrostatic interactions, subsequent 
changes in the peptide secondary structure and aggregation state induced by the membrane 
environment, and ultimately, the killing of the affected organism through permeabilization 
and depolarization following from the loss of membrane integrity (Giuliani et al., 2008). 
However, it has become apparent that a number of AMPs elicit antimicrobial activity in a 
physiologically relevant concentration without the disruption of the permeability barrier 
provided by the cytoplasmic membrane. Recent evidence suggests that these peptides act 
by binding to intracellular targets such as nucleic acids and anionic proteins following 
their translocation across the cellular membranes (Hale and Hancock, 2007). Adding to the 
above controversy, in vitro experiments have a tendency to overestimate the antimicrobial 
efficacy of AMPs, as they are conducted in a low ionic strength medium. Increasing the 
ionic  strength  to  physiologically  relevant  level  suppresses  the  electrostatic  affinity  of  
cationic AMPs to polyanionic membranes, often resulting in reduced membrane 
association and antimicrobial activity under these conditions (Sánchez-Gómez et al., 
2008). Lastly, complementary to their membrane activity, various AMPs have been 
demonstrated to have profound effects on the adaptive and innate immune response of the 
host organism. Unlike conventional antibiotics, these immunomodulatory peptides 
participate in the resolution of infections indirectly by altering host gene expression, 
acting as chemoattractants of immune cells, and modulating the release of cytokines from 
diverse cellular sources (Mookherjee and Hancock, 2007). 
As both oxidative stress and increased activity of AMP-producing cells of the immune 
system are considered hallmarks of inflammation associated with microbial infections, it 
was of interest to investigate the effects of oxidatively modified phospholipids on the 
membrane interactions of AMPs. For this purpose four well-characterized peptides, viz. 
temporins B and L, indolicidin, and LL-37(F27W), were chosen and their binding to 
model membranes was monitored by a Langmuir balance and fluorescence spectroscopy. 
The results of the monolayer penetration experiments reveal intriguing behavior with 
respect to monolayer composition. More specifically, all four peptides intercalated 
efficiently into PoxnoPC containing films from a subphase with physiological ionic 
strength (150 mM NaCl) up to the critical packing density corresponding to ?c values of 
40 (LL-37), 45 (indolicidin), and 50 mN/m (temporin B and L), thus exceeding in all cases 
the equilibrium lateral pressure of ~ 33 mN/m estimated for biomembranes (Demel et al., 
1975). Yet PazePC, despite its negative net charge, failed to promote the monolayer 
association of the positively charged peptides significantly when compared to neat DMPC 
(Fig. 5.8, Fig. 5.9, Table 5.3), which contrasts the above described avid electrostatics-
driven binding of cyt c and cationic drugs to this oxPL. Under low ionic strength 
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conditions the increment in surface pressure induced by the peptides (??) was roughly 
equal for monolayers containing PoxnoPC or the acidic phospholipid DMPG. However, in 
keeping with the screening of electrostatic interactions, the capability of DMPG to 
promote the intercalation of the peptides is drastically attenuated upon increasing the ionic 
strength of the subphase, whereas for the zwitterionic PoxnoPC the values for ?? remain 
essentially unaltered (Table 5.3).  
Valuable information concerning the environment local to the indole side-chain can be 
inferred from the intrinsic Trp fluorescence of polypeptides. This was utilized in the 
present study to gain further molecular level insight into the factors governing the 
interaction of temporin L, indolicidin, and LL-37(F27W) with membranes containing 
oxPLs. Changes in the Trp emission properties of temporin L indicate the peptide 
molecules to be accommodated in a more hydrophobic milieu upon binding to 
DMPC/PoxnoPC (XPoxnoPC = 0.2) LUVs, with an 18 nm blue shift in ?max compared to the 
value recorded in the absence of liposomes. For comparison, the values for ??max induced 
by DMPC/DMPG (XDMPG = 0.2) and neat DMPC liposomes are 24 and 14 nm, 
respectively (Table 5.4). Further, following the addition of PoxnoPC containing liposomes 
the quantum yield for the Trp emission of temporin L is reduced, being approximately half 
of the value recorded in buffer with 150 mM NaCl in the absence of vesicles. In contrast, 
over 1.5 fold increase in fluorescence emission intensity was evident upon partitioning of 
temporin L to DMPC/DMPG LUVs, suggesting the Trp residues to become 
accommodated deep within the membrane hydrophobic core. Interestingly, despite the 
opposite behavior observed in the fluorescence quantum yield, the KSV values of the 
acrylamide quenching measured for Trp of temporin L in the presence of DMPC/PoxnoPC 
and DMPC/DMPG liposomes were nearly identical and substantially lower than for 
DMPC/PazePC or neat DMPC vesicles. This strongly suggests the Trp residue of this 
peptide to reside at approximately equal depth in both DMPG and PoxnoPC containing 
bilayers. Yet, for the former the blue shift in ?max of temporin L is larger, thus indicating 
the environment surrounding the Trp residues of the peptides to be less polar. 
Accordingly, the lower quantum yield observed with PoxnoPC does not originate simply 
from a more interfacial orientation of the peptide molecules, but likely results from 
colocalization of their Trp residues and the polar aldehyde moieties within PoxnoPC 
containing bilayers. In light of the above, one of the factors promoting the association of 
PoxnoPC with AMPs could be efficient hydrogen bonding with the aldehyde moieties 
serving as bond acceptors. The latter reside in a highly anisotropic membrane environment 
and at XPoxnoPC = 0.2 their local content is relatively high. In addition, being contained at 
the end of the sn-2 hydrocarbon chain the aldehydes are embedded in a relatively low 
dielectric milieu which increases the strength (i.e. the dissociation energy) of the formed 
H-bonds compared to those existing in the aqueous phase (Shan et al., 1996). Another 
possibility is the formation of a covalent bond in a form of a Schiff base between the 
aldehyde groups and the primary amines of the peptides, as previously described for the 
covalent binding of PoxnoPC with apolipoprotein A1 (Ahmed et al., 2003). Notably, 
irrespective of the exact molecular mechanism involved, the salient role of the lipid 
aldehyde function in promoting the membrane association of the AMPs was corroborated 
by the inclusion of low-molecular weight aldehyde scavenger methoxyamine, which 
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strongly attenuated the intercalation of temporin L into PoxnoPC containing monolayers. 
In contrast, penetration of temporin L into films with the negatively charged DMPG was 
unaffected by the presence of methoxyamine (III:Fig. 5).  
Because of its five Trps, the fluorescence spectrum of indolicidin is a complex 
convolution of emission originating from the individual residues located in their respective 
microenvironments with slightly differing properties. Therefore the discussion of the 
orientation of indolicidin within membrane environment on the basis of the present results 
is ambiguous. Yet, qualitatively similar results to those of temporin L were obtained for 
indolicidin by acrylamide quenching experiments, with DMPG and PoxnoPC containing 
liposomes yielding the lowest KSV values indicative of efficient shielding of the Trp 
residues within the bilayer. In keeping with previous studies (Sood et al., 2008), the Trp 
fluorescence data for LL-37(F27W) reveal that upon association with phospholipid 
bilayers also Trp of this peptide becomes accommodated in a hydrophobic milieu, with a 
blue shift in emission maximum of ~ 15 nm measured for all lipid compositions (Table 
5.4). However, in contrast to the two other peptides only minor changes in fluorescence 
quantum yield are seen between peptide in aqueous solution and bound to neat DMPC and 
DMPG or PazePC containing LUVs. A possible explanation for this observation is 
quenching arising from peptide conformational changes upon membrane association 
bringing the single Trp in closer proximity to one of the charged residues of LL-
37(F27W). Similarly to temporin L and indolicidin, a significant decrease in emission 
intensity was evident for LL-37(F27W) in the presence of PoxnoPC containing LUVs, 
most likely attributable to direct quenching of Trp fluorescence by the aldehyde moiety. 
In addition to establishing the high affinity of small amphiphilic peptides towards 
oxidatively modified membranes containing lipid aldehydes, the above described 
PoxnoPC – AMP interaction may have implications for the microbicidal action of 
neutrophil granylocytes during phagocytosis. Neutrophils represent an essential 
component of the acute inflammatory response and play a key role in the resolution of 
microbial infections. Following phagocytosis of microorganisms, neutrophil granules 
containing among others antimicrobial proteins and peptides such as lysozyme and 
defensins, fuse with the formed phagosome exposing the engulfed bacteria or other 
microbes to their content. Concomitantly superoxide generated by NADPH oxidase 
residing in the phagosomal membrane is converted into hydrogen peroxide by superoxide 
dismutase inside the phagosome (Mayer-Scholl et al., 2004). It has been suggested that in 
addition to their direct microbicidal effect, generation of these ROS is required to release 
and activate certain cationic proteases inside the phagosome (Roos and Winterbourn, 
2002). In the light of the present results it seems possible that production of ROS and the 
action of AMPs could be interrelated, with ROS induced lipid oxidation in the 
phagolysosome generating high affinity non-electrostatic AMP binding sites on the 
membranes of the microorganisms, which remain active also under physiological ionic 
strength. Accordingly, a novel functional role of aldehyde bearing oxidized phospholipids 
as molecular targets for AMPs is suggested. Furthermore, due to activation of leukocytes 
local oxidative stress and associated damage to cellular membranes is imposed also on the 
tissue affected by microbial inflammation. This may promote the interaction of AMPs 
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with  the  cells  of  the  host  organism  at  the  inflammatory  sites  and  possibly  relate  to  the  
capability of these molecules to stimulate the adaptive immune response. 
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